Episode
3

340B Key Legal Arguments & Future Trends

Co-hosts Chelsea Violette and Logan Yoho take you inside the courtroom in this episode with special guests Mark Ogunsusi & Jason Reddish of Powers Law. From landmark cases to ongoing legal battles, this episode explores the different arguments manufacturers are using to make their case and what it means for stakeholders across the board.

Our Guest on This Episode

our team image
Jason Reddish
Principal, Powers Law

Jason has extensive experience negotiating 340B-related agreements, including those involving covered entities, contract pharmacies, administrators, payers, and others.

our team image
Mark Ogunsusi
Associate, Powers Law

Mark focuses his practice primarily on regulatory matters involving pharmaceutical pricing and, specifically, the 340B federal drug discount program.

View/Hide Transcript

Full Episode Transcript

00:00:00.017 --> 00:00:05.237

Welcome to the 340 Banter podcast. Today, we're joined by Mark Ogunshusi,

00:00:05.537 --> 00:00:07.697

as well as Jason Reddish from Powers Law.

00:00:08.097 --> 00:00:12.577

We'll be discussing recent legal arguments pharmaceutical manufacturers have

00:00:12.577 --> 00:00:17.677

been using inside the courts, as well as what we see coming down the road in litigation.

00:00:18.357 --> 00:00:22.857

Even though Mark and Jason are lawyers, you should not use this as legal advice

00:00:22.857 --> 00:00:24.617

and should consult general counsel.

00:00:45.157 --> 00:00:49.737

All right. So 340B has been really rampant in the courtrooms lately,

00:00:49.917 --> 00:00:51.737

both at the state and the federal level.

00:00:51.857 --> 00:00:55.237

So I was wondering if we could kind of go through today and get your insights

00:00:55.237 --> 00:00:59.617

from the legal perspective, both of us being pharmacists, and maybe go through

00:00:59.617 --> 00:01:02.937

some of the arguments that have come up in those court cases lately.

00:01:03.617 --> 00:01:06.137

Yeah, I mean, that sounds like a good idea, but we're going to keep it,

00:01:06.157 --> 00:01:08.077

you know, related to pharmacists.

00:01:08.417 --> 00:01:11.657

We're not talking to lawyers, we're talking to pharmacists. It was a lot easier

00:01:11.657 --> 00:01:15.697

when there were only like two 340B cases for the first 30 years to keep track of.

00:01:16.037 --> 00:01:19.097

Oh, yeah. Well, we talked about, you know, going through case by case,

00:01:19.157 --> 00:01:21.317

but we would be here for weeks. So we're going to go back.

00:01:21.557 --> 00:01:23.917

And we would need a lot of paper in front of us, which would not be helpful.

00:01:23.917 --> 00:01:25.237

We'll go by arguments instead at this point.

00:01:25.997 --> 00:01:30.097

So let's kick us off. I think preemption is one of the first ones that had come up.

00:01:30.257 --> 00:01:34.077

You want to talk us kind of through what that is and how that's played out in the court cases so far.

00:01:34.157 --> 00:01:38.137

Yeah. So my pharmacists out there, we're dealing with these state laws that

00:01:38.137 --> 00:01:40.757

require drugs to be shipped to your pharmacies.

00:01:41.677 --> 00:01:46.897

And, you know, the drug makers, manufacturers don't like these state laws because

00:01:46.897 --> 00:01:52.197

they require that these discounted medications that safety net providers provide

00:01:52.197 --> 00:01:53.537

are shipped to your pharmacies.

00:01:53.617 --> 00:01:58.437

And they're saying, no, federal law is the absolute, because 340 is a federal

00:01:58.437 --> 00:02:01.177

pricing statute, right? That's where the price occurs.

00:02:01.437 --> 00:02:04.457

Say it's absolute, leaves no room for state law. So therefore,

00:02:04.737 --> 00:02:06.077

it preempts the state law.

00:02:06.297 --> 00:02:09.577

So any state law relating to delivery, and we all know there's all sorts of

00:02:09.577 --> 00:02:13.377

state laws relating to delivery, wholesaler laws and things of that nature,

00:02:13.517 --> 00:02:15.397

controlled substance laws related to distribution.

00:02:16.585 --> 00:02:21.905

Somehow, spontaneously, a federal pricing statute allegedly preempts or supplants

00:02:21.905 --> 00:02:27.025

or should take the place of or cancels out the state law. And that's preemption.

00:02:27.465 --> 00:02:30.305

So that's the argument. I don't know if you wanted to get into the disposition

00:02:30.305 --> 00:02:35.245

of these cases. So I think we've seen a lot of success at the state level.

00:02:35.485 --> 00:02:39.545

And so obviously that argument is not working.

00:02:39.765 --> 00:02:45.645

Is that what we're seeing? Yeah, at the federal court level,

00:02:45.785 --> 00:02:51.465

but looking at state laws, they've found that the 340B statute doesn't address delivery.

00:02:51.825 --> 00:02:57.345

It addresses pricing and addresses some other aspects of acquiring the drugs,

00:02:57.365 --> 00:03:01.125

but it doesn't speak to whether drugs have to be shipped to a certain place

00:03:01.125 --> 00:03:06.185

or whether manufacturers have to ship to where the covered entity wants them to be shipped.

00:03:06.745 --> 00:03:10.205

So the preemption arguments have largely fallen flat.

00:03:10.725 --> 00:03:14.985

They were also hurt a little bit because on the cases that challenged whether

00:03:14.985 --> 00:03:19.225

manufacturers could impose restrictions on contract pharmacy restrictions,

00:03:19.405 --> 00:03:22.685

their whole argument is, well, there's a huge gap in the statute. It just says offer.

00:03:22.865 --> 00:03:25.905

So we can fill that gap. If there's a huge gap in the statute,

00:03:26.105 --> 00:03:28.985

it obviously doesn't occupy all of the 340B field.

00:03:29.125 --> 00:03:33.605

And there was room for state regulation in areas that states typically regulate shipments.

00:03:33.985 --> 00:03:36.545

I want to add to what Jason's name is. we're talking to pharmacists, right?

00:03:36.985 --> 00:03:40.565

I mean, how complex is the practice of pharmacy? How many variations do we see?

00:03:40.905 --> 00:03:45.245

We see institutional pharmacy at hospitals. We see retail pharmacies.

00:03:45.365 --> 00:03:48.225

We see long-term care pharmacies. We see infusion pharmacies.

00:03:48.785 --> 00:03:52.345

And state laws govern the practice of pharmacy. In fact, Jason,

00:03:52.865 --> 00:03:54.965

does the 340 statute even mention the term pharmacy?

00:03:55.165 --> 00:03:57.225

No, the word pharmacy is not used anywhere. Not once.

00:03:57.565 --> 00:04:00.165

So why are the drug makers saying that the federal law preempts the state law?

00:04:00.285 --> 00:04:04.225

I don't know. I don't know. All right. Well, then we'll move on from preemption.

00:04:05.025 --> 00:04:09.865

Next one we've seen is the Dormant Commerce Clause. I mean, that's a mouthful.

00:04:10.045 --> 00:04:12.165

The Dormant Commerce Clause.

00:04:12.405 --> 00:04:16.565

Long story short, for my pharmacists out there, they believe these state delivery

00:04:16.565 --> 00:04:21.865

laws regulate Honda transactions occurring completely out of the state.

00:04:22.025 --> 00:04:26.905

It's an old constitutional law concept that interstate commerce,

00:04:26.905 --> 00:04:28.585

the federal government can regulate.

00:04:28.785 --> 00:04:33.645

And they're saying that a state law that requires the drug maker to not block

00:04:33.645 --> 00:04:37.545

or limit delivery of these discounted drugs to the pharmacies,

00:04:37.725 --> 00:04:41.085

to your pharmacy, regulates out-of-state conduct.

00:04:41.425 --> 00:04:47.125

You know, the drug makers just spontaneously, after years of delivering drugs into states,

00:04:47.705 --> 00:04:52.405

now states can't regulate these deliveries because some drug makers are located

00:04:52.405 --> 00:04:55.245

in that state, some drug makers are located in that state, but at the end of

00:04:55.245 --> 00:04:57.605

the day, they know their drugs are getting to your state.

00:04:57.985 --> 00:05:02.525

And again, that's another argument that I think is a bit spurious, spurious, spurious,

00:05:03.073 --> 00:05:07.373

You know, I haven't seen a new word for me. Well, it's unreasonable.

00:05:10.693 --> 00:05:15.973

It's well, it's unreasonable. I mean, it's like these are old constitutional

00:05:15.973 --> 00:05:18.493

contentions that have never gone anywhere.

00:05:18.713 --> 00:05:23.793

And there's plenty of case law establishing that states can regulate delivery

00:05:23.793 --> 00:05:25.273

of drugs within their borders. Yeah.

00:05:25.413 --> 00:05:30.073

And so, you know, what we've seen is failure by the drug makers on that.

00:05:30.153 --> 00:05:32.693

In fact, they're dropping those claims, that claim. They're not really even

00:05:32.693 --> 00:05:33.933

included in their litigation.

00:05:34.313 --> 00:05:38.753

And there are plenty of state laws that have impacts on activities outside of the state.

00:05:38.873 --> 00:05:42.513

I mean, one thing I use, I think of often when you're talking about this,

00:05:42.693 --> 00:05:46.033

it's called the Dormant Commerce Clause because the idea is if the federal government

00:05:46.033 --> 00:05:49.353

can regulate commerce between the states, then states can't do anything that

00:05:49.353 --> 00:05:51.013

hinders commerce between states.

00:05:51.093 --> 00:05:53.613

Yeah, that makes sense. But you think about, we watched game shows growing up.

00:05:53.693 --> 00:05:55.693

You've got the California emission standards.

00:05:55.913 --> 00:05:58.453

Like every car was up to the California emission standards.

00:05:58.853 --> 00:06:02.193

They're the biggest market. If they set an emission standard and they're allowed

00:06:02.193 --> 00:06:05.553

to under state law, that's going to affect everybody out of state because they're

00:06:05.553 --> 00:06:08.453

probably going to go down to that standard to be able to ship drugs to,

00:06:08.633 --> 00:06:09.933

I mean, ship cars to California.

00:06:10.553 --> 00:06:14.633

So it's not unusual for a state to have a minimum standard for their own state

00:06:14.633 --> 00:06:17.453

that is going to affect people who want to ship into the state.

00:06:17.453 --> 00:06:21.293

As long as it applies equally to a drug manufacturer in Arkansas as it does

00:06:21.293 --> 00:06:23.733

to one in New York, then there's not really an impact. Yeah,

00:06:23.893 --> 00:06:24.913

that's a great explanation.

00:06:26.218 --> 00:06:29.158

All right. So the next one we've got is due process takings.

00:06:29.358 --> 00:06:34.718

So this is what they're really kind of focusing on lately, which is that,

00:06:34.838 --> 00:06:35.718

you know, the government,

00:06:36.058 --> 00:06:41.238

state or federal government can't take private property from private individuals

00:06:41.238 --> 00:06:43.438

or entities without just compensation.

00:06:43.918 --> 00:06:47.858

And so I mentioned we have this is all about the 340B federal pricing statute.

00:06:47.858 --> 00:06:49.598

That's nothing about delivery or distribution.

00:06:50.118 --> 00:06:55.078

But they're alleging that because the statute sets a price that these coverings

00:06:55.078 --> 00:06:58.658

can pay and the state law says you must deliver it to where the coverings say

00:06:58.658 --> 00:07:01.518

you should deliver it, that that's taking their property.

00:07:01.638 --> 00:07:04.958

They have patents and they should be able to set their prices unreasonably high.

00:07:05.078 --> 00:07:09.058

I'm not going to get crazy, but we know drug makers are 300 to 1,000 percent

00:07:09.058 --> 00:07:11.158

in the United States and the other developed country in the world.

00:07:11.158 --> 00:07:15.458

We know we're being screwed here in the United States, but they're saying that

00:07:15.458 --> 00:07:17.958

that's a taking and that they weren't justly compensated.

00:07:18.598 --> 00:07:21.918

But, you know, the counterargument to that, similar to with the inflation reduction

00:07:21.918 --> 00:07:24.438

for my pharmacist, Medicare negotiated prices,

00:07:25.038 --> 00:07:30.478

discounted Medicare drugs, is that the drug makers voluntarily participate in

00:07:30.478 --> 00:07:34.098

the 340B program so that their drugs are covered under Medicare and Medicaid.

00:07:34.298 --> 00:07:37.658

The business decision at the end of the day. Well, it's a really good business decision.

00:07:38.258 --> 00:07:41.978

How much taxpayer, I mean, how much money do you think these companies are making

00:07:41.978 --> 00:07:45.838

off of Medicare and Medicaid in exchange for giving some safety net providers

00:07:45.838 --> 00:07:48.298

critical discounts to keep our country moving?

00:07:48.738 --> 00:07:54.138

Billions and billions of dollars. Have we seen that actually go through any

00:07:54.138 --> 00:07:58.358

court cases yet? Has it been successful? Actually, on the Inflation Reduction

00:07:58.358 --> 00:08:00.718

Act side, it's been rejected repeatedly.

00:08:00.918 --> 00:08:04.098

The taking cost. And it actually makes a lot more sense on that side,

00:08:04.238 --> 00:08:08.298

where they say, I've got this patent window, and now you're telling me that

00:08:08.298 --> 00:08:13.178

I have to submit to your price, basically, or pay an incredibly high tax.

00:08:14.218 --> 00:08:16.938

And if I don't, my only other option is drop out of Medicare.

00:08:17.398 --> 00:08:19.918

And so they're saying we're being hijacked to do it.

00:08:19.998 --> 00:08:23.838

And the counter argument is Medicare is the biggest drug market in the world.

00:08:24.098 --> 00:08:27.338

It's one of the best payers in the world. If you want access to that market,

00:08:27.498 --> 00:08:28.958

you have to play by that market's rules.

00:08:29.478 --> 00:08:34.298

And for the most part, that is that is largely succeeded and knocked down the

00:08:34.298 --> 00:08:35.278

manufacturer arguments.

00:08:35.578 --> 00:08:40.138

You know, whether the IRA survives a change in in the House or presidency is

00:08:40.138 --> 00:08:44.198

probably a bigger conversation or whether it survives with changes is probably a bigger conversation.

00:08:44.218 --> 00:08:48.178

But the due process arguments have not gotten them over the finish line.

00:08:48.478 --> 00:08:51.218

You can't take what you're voluntarily participating in.

00:08:51.558 --> 00:08:54.938

Yeah, there's an option that the manufacturers could choose to not be part of

00:08:54.938 --> 00:08:58.498

the pharmacy pricing agreement, which would remove them from Medicaid and Medicare,

00:08:58.738 --> 00:09:03.638

but would also remove them from the 340B program. PBM contracts are terrible.

00:09:03.858 --> 00:09:07.698

You could choose not to contract with the major PBMs. You won't be able to run

00:09:07.698 --> 00:09:09.278

a pharmacy, but you could choose that.

00:09:09.578 --> 00:09:13.698

Well, yeah, of course. I think one thing to add on to the PBM situation,

00:09:13.698 --> 00:09:17.518

if I'm a pharmacy, is that I'm not, by signing this PBM contract,

00:09:17.658 --> 00:09:20.658

making billions and billions of taxpayer dollars.

00:09:20.978 --> 00:09:25.038

I mean, these drug companies are making massive amounts by, you know,

00:09:25.178 --> 00:09:28.858

participating in the 340B program because their drugs are covered under a separate

00:09:28.858 --> 00:09:32.598

program, Medicare, Medicaid, and other programs. I mean, they're killing it.

00:09:32.698 --> 00:09:35.778

I mean, I mean, anyways, I'm not going to get into it. They make a lot of money.

00:09:35.858 --> 00:09:36.698

Let's just put it that way.

00:09:37.438 --> 00:09:40.338

Really? I didn't get that message. They're doing okay. Stop punching down.

00:09:40.658 --> 00:09:44.958

Okay. All right. So we'll move on to the contracts clause. The next one we're seeing.

00:09:45.478 --> 00:09:48.918

Yeah, this one's pretty simple. The drug makers are saying, you know,

00:09:49.058 --> 00:09:52.078

by requiring us to deliver drugs to where the patients can actually pick them

00:09:52.078 --> 00:09:57.058

up, you're modifying our contracts with, let's say, wholesalers or other contracts that they have.

00:09:57.358 --> 00:10:02.978

And, you know, again, none of these claims have won in any federal court. You know, they're.

00:10:03.533 --> 00:10:09.653

Untenable propositions that, you know, really would upset decades-long practice.

00:10:09.953 --> 00:10:11.433

You know, there's plenty of regulations

00:10:11.433 --> 00:10:13.833

on it. Let's talk about state-controlled substance laws, right?

00:10:14.073 --> 00:10:18.313

That modifies a wholesaler contract. You know, there's plenty of state laws

00:10:18.313 --> 00:10:21.113

that have impacts on your contracts.

00:10:21.233 --> 00:10:25.473

The bottom line is states are free to protect public health and safety within their borders.

00:10:25.793 --> 00:10:31.073

And, you know, I hope the drug makers get with the public health program and

00:10:31.073 --> 00:10:32.833

stop these spurious arguments.

00:10:33.473 --> 00:10:36.533

Yeah, I mean, contracts clause is a tough thing to argue. Basically,

00:10:36.613 --> 00:10:40.653

there's a line in the Constitution that says no state shall impair the obligation of contracts.

00:10:40.973 --> 00:10:45.393

But that could be like, I'm going to pass a law that says Logan Yoho doesn't

00:10:45.393 --> 00:10:49.133

owe his mortgage to that bank in Ohio anymore. You're lucky that. Yeah.

00:10:51.033 --> 00:10:55.753

It's not, there are a lot of exceptions in balancing tests when you're imposing

00:10:55.753 --> 00:11:00.673

regulations that help health and safety that happen to have an impact on existing contracts.

00:11:00.933 --> 00:11:04.593

So one of the things I like about talking through these arguments and explaining

00:11:04.593 --> 00:11:10.053

them to somebody that's not a lawyer is that what we're seeing is that in some

00:11:10.053 --> 00:11:13.133

states they're considering this, but there's fears of this litigation.

00:11:13.133 --> 00:11:18.673

So it's really good that we're discussing this and showing that these arguments

00:11:18.673 --> 00:11:19.593

haven't been successful.

00:11:19.813 --> 00:11:23.533

I think there's value there. And we went from Louisiana, I mean,

00:11:23.553 --> 00:11:28.953

Arkansas to Arkansas and Louisiana to Arkansas, Louisiana, Maryland,

00:11:29.053 --> 00:11:34.133

Mississippi, Missouri, Minnesota, Kansas, West Virginia in like three and a half, four years.

00:11:34.293 --> 00:11:38.433

And there were probably another five or six states that there was fear.

00:11:38.633 --> 00:11:41.873

Well, we don't want to get sued or we're afraid that we'll get pulled into this litigation.

00:11:42.213 --> 00:11:47.333

Every time one of these states wins, it makes it easier and easier to pass a law in another state.

00:11:47.513 --> 00:11:50.933

So maybe we go from eight now to 15 next year. Yeah.

00:11:51.493 --> 00:11:55.053

Especially if there's fear about what's going to happen at the federal level.

00:11:55.213 --> 00:11:59.013

Yeah, I think that could play in as a positive at the state level.

00:11:59.133 --> 00:12:01.653

Yeah, when you read the opinions, the judges aren't even...

00:12:02.498 --> 00:12:05.278

I mean, they're duly considering the drug maker's arguments,

00:12:05.278 --> 00:12:09.098

but they're, you know, they're slapping them down back and forth.

00:12:09.338 --> 00:12:13.418

So really, we're just talking about multinational, highly profitable companies

00:12:13.418 --> 00:12:14.638

that have the money to sue,

00:12:14.918 --> 00:12:18.518

to slow down enforcement against them so that they continue to drive up shareholder

00:12:18.518 --> 00:12:21.598

value and make more money, money, money, money on the backs of our community

00:12:21.598 --> 00:12:24.278

pharmacies, on the backs of our patients who are in underserved communities,

00:12:24.458 --> 00:12:28.898

on the backs of our safety net providers and public health providers throughout the country. Yeah.

00:12:29.178 --> 00:12:32.238

I'm going to take us to an argument that's not a constitutional argument,

00:12:32.358 --> 00:12:37.738

but one we're seeing come up, I think, a lot more recently is the kind of questioning

00:12:37.738 --> 00:12:40.158

the replenishment system and maintaining the title of the drug.

00:12:40.758 --> 00:12:44.418

Yeah, so that fits within a constitutional argument. It fits within,

00:12:44.578 --> 00:12:48.238

you know, AstraZeneca is alleging that in Arkansas, for example.

00:12:48.498 --> 00:12:52.658

But it fits within the due process takings, like taking property without just

00:12:52.658 --> 00:12:54.098

compensation, like patented property.

00:12:54.358 --> 00:12:57.838

And it fits within the preemption. They're saying that the 340 statute says

00:12:57.838 --> 00:13:01.698

a covered entity, the safety net provider who's entitled to purchase the drug,

00:13:01.858 --> 00:13:06.098

shall not transfer the drug to anyone other than a person, a patient,

00:13:06.258 --> 00:13:07.398

a patient of the covered entity.

00:13:07.558 --> 00:13:09.818

Yes. Right. Which has been around since the beginning of time.

00:13:10.158 --> 00:13:14.318

So the drug makers are saying replenishment, you know, where the drug is dispensed,

00:13:14.598 --> 00:13:19.098

a drug is dispensed, and a drug replenishes the drug, that's all I'm going to say about it,

00:13:19.458 --> 00:13:22.938

violates the transfer prohibition, and it's a taking of their property,

00:13:23.038 --> 00:13:25.438

their discounted drugs. Now, let's just think about it.

00:13:26.642 --> 00:13:29.502

Replenishment it's just an inventory accounting system first in

00:13:29.502 --> 00:13:32.362

first out yada yada has been around since before

00:13:32.362 --> 00:13:35.662

establishment of the united states it's well established

00:13:35.662 --> 00:13:38.642

that when a party is

00:13:38.642 --> 00:13:44.182

has some inventory especially fungible goods you know you don't have to account

00:13:44.182 --> 00:13:48.522

with detailed particularity one product versus another product they're fungible

00:13:48.522 --> 00:13:51.602

they're inter place they're interchangeable for example when i put money into

00:13:51.602 --> 00:13:55.642

the bank and the bank mixes that money up with all the other money in the bank.

00:13:55.782 --> 00:13:57.862

That doesn't mean the bank automatically owns your money.

00:13:58.302 --> 00:14:01.442

The bank is just holding that money on your behalf. You're also not getting

00:14:01.442 --> 00:14:04.162

the exact same, you know, dollar bill back.

00:14:04.622 --> 00:14:07.442

Yeah, you're not getting the serial number. Yeah. Well, yeah.

00:14:07.602 --> 00:14:09.822

And look, I'm not going to get into the legal arguments, but at the end of the

00:14:09.822 --> 00:14:14.902

day, and Jason probably wants to talk more about this, after decades-long practice,

00:14:15.022 --> 00:14:17.342

replenishment systems were used before 340B was enacted.

00:14:17.642 --> 00:14:22.942

Under Nonprofit Institution Act, for example, for, you know, own-use hospitals.

00:14:23.542 --> 00:14:28.082

You know, the thing is, is that after 30 years of practice or more,

00:14:28.342 --> 00:14:32.142

these drug companies are now all of a sudden saying, you know,

00:14:32.262 --> 00:14:34.642

we've been dealing with this, this has been going on.

00:14:34.942 --> 00:14:38.622

It's even more accurate than physically separating the product because you trace

00:14:38.622 --> 00:14:40.622

each drug on an 11-digit.

00:14:40.722 --> 00:14:44.122

Every pill that goes out, you make sure that went to a patient, right?

00:14:44.362 --> 00:14:47.982

They're saying that now it's illegal. Just so you can understand how we feel

00:14:47.982 --> 00:14:51.142

in the covered in the community after 30 years, all of a sudden,

00:14:51.222 --> 00:14:53.642

oh, no, that's illegal. No, you guys are taking my property.

00:14:54.282 --> 00:14:58.922

And actually, it's a good segue into everything that manufacturers are looking

00:14:58.922 --> 00:15:00.902

at that maybe they haven't challenged before.

00:15:01.182 --> 00:15:05.362

A lot of people don't know that pharma filed suit against HRSA in 1996 when

00:15:05.362 --> 00:15:08.782

the first contract pharmacy guidance came out and they actually pulled it back

00:15:08.782 --> 00:15:10.782

because of pushback from Ryan White Clinics.

00:15:11.500 --> 00:15:16.340

So, you know, they were they had an opportunity when this was announced in 1996

00:15:16.340 --> 00:15:20.660

to litigate it and fight over whether the program allowed contract pharmacies.

00:15:20.860 --> 00:15:26.000

They didn't. Now they come back literally 24 years later and they start self-imposing

00:15:26.000 --> 00:15:27.500

some restrictions on the program.

00:15:27.700 --> 00:15:33.260

Does that impact their, I don't know, have a leg to stand on when you're making

00:15:33.260 --> 00:15:36.440

that argument when you've not challenged it for 25 years?

00:15:36.440 --> 00:15:40.420

There is a legal concept. It's called latches, which literally means you delayed

00:15:40.420 --> 00:15:43.900

so long that it's unfair to the person that you're trying to enforce it against.

00:15:44.100 --> 00:15:47.880

It doesn't apply as often when you're dealing with challenging a government

00:15:47.880 --> 00:15:49.800

aspect, but it is a factor.

00:15:49.980 --> 00:15:53.220

I mean, that you voluntarily participated in this model.

00:15:53.480 --> 00:15:58.880

You knew who you were shipping the drugs to for 20 years and you didn't balk at it then.

00:15:59.500 --> 00:16:02.680

But manufacturers are trying to challenge the replenishment model.

00:16:02.680 --> 00:16:07.440

If you think about risk-reward for them, if they were somehow able to get rid

00:16:07.440 --> 00:16:11.140

of replenishment, you would cut the contract pharmacy market in half.

00:16:11.320 --> 00:16:13.700

You would have problems with hospitals and split billing.

00:16:13.980 --> 00:16:17.820

Yeah, hospitals wouldn't be able to manage their clinic-administered or physician-administered

00:16:17.820 --> 00:16:20.460

drugs. They would have to severely limit where they can use 340B.

00:16:20.580 --> 00:16:23.160

And a lot of health centers, even their entity-owned pharmacies,

00:16:23.160 --> 00:16:26.640

are virtual in nature. Depending on Medicaid carve-out and things like that,

00:16:26.700 --> 00:16:29.900

you may have single neutral inventory there.

00:16:30.100 --> 00:16:36.320

Yeah. So you're talking about maybe cutting the volume of 340B purchasing nationwide by $30 billion.

00:16:36.940 --> 00:16:41.660

And they're going to spend some money to try that. And it's not for the purpose. Let's just be clear.

00:16:42.100 --> 00:16:47.040

It's not for the purpose of greater, you know, we don't want this because it'll

00:16:47.040 --> 00:16:51.300

be more accurate if you maintain a separate inventory. Because the second you

00:16:51.300 --> 00:16:55.080

dispense a drug out of a physically separate inventory to a non-patient,

00:16:55.300 --> 00:16:56.700

that's diversion, right?

00:16:56.820 --> 00:17:01.500

There's no opportunity to true up. There's no opportunity to account for the

00:17:01.500 --> 00:17:03.440

pills that are fungible, that are mixable.

00:17:03.800 --> 00:17:07.420

So it really is just an opportunity to do what Jason is saying,

00:17:07.980 --> 00:17:08.780

challenging replenishment.

00:17:09.000 --> 00:17:14.140

It's just to save money. It's just to make money. It's just a multinational profit.

00:17:14.440 --> 00:17:18.060

Or to make things more complicated to the point that you can no longer comply.

00:17:18.300 --> 00:17:24.240

And therefore, you can charge your extremely 300 to 1,000% high list price drugs. Yeah. Anyways.

00:17:24.620 --> 00:17:27.740

All right. Right. So I've got one more constitutional argument for us to hit

00:17:27.740 --> 00:17:32.860

on that's been seen in some of the cases we've seen so far, but seems to be less frequent now.

00:17:33.700 --> 00:17:37.320

Unconstitutional vagueness, which sounds to me just pretty, pretty vague.

00:17:37.520 --> 00:17:40.760

Like it seems like it's pretty self-explanatory. story yeah yeah

00:17:40.760 --> 00:17:43.420

the bottom line is if you're going to

00:17:43.420 --> 00:17:46.340

punish somebody for violating a law they have to know what they're

00:17:46.340 --> 00:17:50.820

prohibited from doing so you know if you have a law in the books that says anybody

00:17:50.820 --> 00:17:56.060

who is is performing vagrancy will be charged with a misdemeanor and you ask

00:17:56.060 --> 00:17:59.200

somebody what is vagrancy and they come up with whatever decision they whatever

00:17:59.200 --> 00:18:02.320

definition they want that's going to be unconstitutionally vague can't create

00:18:02.320 --> 00:18:03.740

a criminal record for someone because.

00:18:06.126 --> 00:18:11.826

Manufacturers have tried to argue that some of the language in these state statutes

00:18:11.826 --> 00:18:14.246

is unconstitutionally vague.

00:18:14.466 --> 00:18:17.426

And I think they've been shut out. I know they've been shut out on those.

00:18:17.546 --> 00:18:20.046

And I think they've stopped really raising that argument.

00:18:20.386 --> 00:18:23.626

Yeah, I think they've stopped raising the argument. If you want an opinion,

00:18:23.766 --> 00:18:28.806

you can look at the Louisiana lawsuits, plural with Pharma and AstraZeneca,

00:18:29.166 --> 00:18:32.486

that they lost with flying colors because the law is pretty clear.

00:18:33.026 --> 00:18:36.426

But unconstitutional vagueness, I mean, a law that says you must not limit delivery

00:18:36.426 --> 00:18:38.046

of a product is pretty concrete.

00:18:38.226 --> 00:18:41.966

I mean, what they want you to do, what they want to do is obfuscate very clear

00:18:41.966 --> 00:18:47.326

laws such that they can create grounds to invalidate them and make more money.

00:18:47.486 --> 00:18:49.506

But at the end of the day, don't limit delivery.

00:18:49.706 --> 00:18:54.406

Your policy specifically references distribution and limiting distribution and

00:18:54.406 --> 00:18:55.426

or prohibiting distribution.

00:18:55.926 --> 00:19:00.066

And that's pretty concrete. And that's why the unconstitutional vagueness argument

00:19:00.066 --> 00:19:03.626

has not, you know, it doesn't have legs. It hasn't had any legs.

00:19:03.926 --> 00:19:08.226

Courts basically have said, you know, under basic case law, we can read the

00:19:08.226 --> 00:19:10.646

statute in a way that's concrete. Right.

00:19:10.846 --> 00:19:13.766

I mean, if you're writing statutes for a state, if you're helping work on a

00:19:13.766 --> 00:19:16.286

bill for your state, you can have it in the back of your mind.

00:19:16.306 --> 00:19:20.406

But the Legislative Council, one of their jobs when they prepare a bill for

00:19:20.406 --> 00:19:23.766

the state is to look for constitutional issues. And that's always going to be

00:19:23.766 --> 00:19:24.606

something they look for.

00:19:24.806 --> 00:19:28.506

So it's already gone through a layer before it gets passed of somebody deciding

00:19:28.506 --> 00:19:30.066

it's not vague. All right.

00:19:30.226 --> 00:19:33.906

So now I kind of want to pivot. And we've talked about the arguments that we've

00:19:33.906 --> 00:19:38.566

seen that are going on in the courtroom right now or have been and say,

00:19:38.726 --> 00:19:41.006

looking forward, what what can we expect?

00:19:41.146 --> 00:19:43.866

Are we going to see some, you know, a lot of the same arguments,

00:19:44.026 --> 00:19:48.206

a lot of the same issues? Are we going to see some new issues coming up? I think new issues.

00:19:48.466 --> 00:19:52.366

So two things that we've been dealing with, and really one of them is now a

00:19:52.366 --> 00:19:57.346

year old, is manufacturers, at least one manufacturer, seeking and obtaining

00:19:57.346 --> 00:20:03.106

permission from HRSA to audit a health center for Medicaid managed care duplicate discounts. Yeah.

00:20:05.559 --> 00:20:09.999

More than a decade, Hearst has said, we don't have any jurisdiction over managed care.

00:20:10.319 --> 00:20:12.759

We're not going to issue. At one point, they said, we're going to issue policy

00:20:12.759 --> 00:20:15.959

in conjunction with CMS on managed care. Then they came back and said, no, we're not.

00:20:16.339 --> 00:20:20.059

Just kidding. Yeah. And the statute itself is written in a way that treats fee-for-service

00:20:20.059 --> 00:20:21.219

differently than managed care.

00:20:21.539 --> 00:20:25.659

When they expanded the rebate program to include managed care in 2010,

00:20:25.979 --> 00:20:29.579

they included a provision that said if the drug's purchased on a 340B account

00:20:29.579 --> 00:20:32.899

and billed to a managed care plan, it's not eligible for a rebate.

00:20:33.099 --> 00:20:37.019

We're only prohibited from billing Medicaid for drugs that are eligible for a rebate.

00:20:37.279 --> 00:20:40.159

So they kind of took it all away from 340B and HRSA.

00:20:40.559 --> 00:20:43.579

It was a big shock. We fought pretty hard.

00:20:43.879 --> 00:20:48.619

HRSA did not relent. They allowed this manufacturer to audit the covered entity.

00:20:48.799 --> 00:20:53.019

The audit actually took place about seven months ago. We still don't have a response.

00:20:53.219 --> 00:20:57.679

They rode this health center hard to make them submit documents and move along.

00:20:57.819 --> 00:21:03.059

And we're not really sure why suddenly HRSA, which has never issued any position

00:21:03.059 --> 00:21:07.739

of its own on managed care, is now letting a drug manufacturer essentially make up the rules.

00:21:08.079 --> 00:21:12.059

Because if there's no rule from HRSA to look at, what rule is the manufacturer?

00:21:12.199 --> 00:21:19.679

And a lot of states have very vague language on how to prevent a rebate in the MCO space.

00:21:19.679 --> 00:21:24.119

Yeah. In this particular case, during the time period, there was no rule for

00:21:24.119 --> 00:21:27.759

managed care claims at the state level and none at the payer level either.

00:21:27.759 --> 00:21:29.719

So I have two follow-ups with that, right?

00:21:29.819 --> 00:21:34.519

So you're saying that's a potential dispute in the future, maybe against HRSA

00:21:34.519 --> 00:21:38.619

for permitting the audit by the drugmaker in the first instance,

00:21:38.699 --> 00:21:41.979

or even obligating the covered entity in any way to be involved in something

00:21:41.979 --> 00:21:42.799

that's not responsible for.

00:21:42.799 --> 00:21:45.639

So my question is, who is responsible?

00:21:45.859 --> 00:21:48.779

So firstly, what you just said made it seem to me, and correct me if I'm wrong.

00:21:49.299 --> 00:21:54.979

That once a covered entity chooses to purchase a 340B drug, the rebateability

00:21:54.979 --> 00:21:57.219

of the drug is extinguished.

00:21:57.339 --> 00:22:01.899

So therefore, the state can't request a rebate once the covered entity chooses to purchase the drug.

00:22:01.959 --> 00:22:06.879

Is that right? Well, the state can write laws and impose rules on when a 340B

00:22:06.879 --> 00:22:09.419

entity can use 340B drugs to bill MCOs.

00:22:09.559 --> 00:22:13.259

They can do that through their contracts with the MCOs and tell the MCOs,

00:22:13.339 --> 00:22:16.779

you're going to tell pharmacies they cannot use 340B drugs.

00:22:16.799 --> 00:22:21.819

Or they can issue a statewide regulation or even pass a law that says you can't

00:22:21.819 --> 00:22:25.359

use 340B drugs when you bill managed care. A lot of states haven't done anything.

00:22:26.238 --> 00:22:31.038

There's nothing on the books about how to do it. And you look at each MCO contract

00:22:31.038 --> 00:22:32.918

or manual and there's nothing there.

00:22:33.078 --> 00:22:37.218

It's so hard to find information. I know we work with health centers all over

00:22:37.218 --> 00:22:43.098

the country to find information about even what MCOs, what PBM they're using.

00:22:43.598 --> 00:22:48.278

And sometimes you find a bulletin and it's just posted on a website somewhere.

00:22:48.518 --> 00:22:53.378

And the lawyer will say, this tears up all of my managed care contracts,

00:22:53.378 --> 00:22:56.378

this bulletin that they just posted. There's no notice and comment.

00:22:56.638 --> 00:23:01.058

There was no official process. They just put a notice on the website and now

00:23:01.058 --> 00:23:04.478

I'm supposed to give up $5 million in managed care bill.

00:23:04.618 --> 00:23:08.078

I mean, it hasn't been handled well in many states.

00:23:08.318 --> 00:23:12.118

Some states have, but in many states it was pretty much ignored.

00:23:12.378 --> 00:23:14.938

And then it got to be a bigger problem for manufacturers.

00:23:15.258 --> 00:23:18.278

And I think HRSA doesn't really know what to do at this point.

00:23:18.278 --> 00:23:22.698

Well, so my question is around the manufacturer audit in HRSA,

00:23:22.878 --> 00:23:26.038

I guess it could be looked at one of two ways.

00:23:26.158 --> 00:23:31.518

Either, you know, condoned it or didn't present a strong front to it.

00:23:31.878 --> 00:23:38.338

Is the timing of kind of Chevron deference in HRSA having less of a say,

00:23:38.798 --> 00:23:41.338

potentially, you know, playing into that?

00:23:41.338 --> 00:23:45.678

I mean, this is actually an area where they have some statutory cover,

00:23:45.838 --> 00:23:50.338

where the statute says that they can, manufacturers can audit under the basically

00:23:50.338 --> 00:23:53.538

conditions that the secretary, which is HRSA, allows.

00:23:53.798 --> 00:23:58.178

So they actually had a little bit of strength here where they put out a policy

00:23:58.178 --> 00:24:01.338

in accordance with notice and comment that may actually have some...

00:24:02.283 --> 00:24:07.163

Some legal effect. Now, somebody else could look at it now, post-Chevron means

00:24:07.163 --> 00:24:10.263

a judge could look at it and reach their own interpretation of what that means.

00:24:10.763 --> 00:24:15.763

But I think this, it could have been a political call that, you know,

00:24:15.903 --> 00:24:21.103

this manufacturer has been beat up pretty bad by HHS on the IRA and some other

00:24:21.103 --> 00:24:22.603

things, so let's let them have this.

00:24:22.843 --> 00:24:24.963

It could have just been a poor decision.

00:24:25.303 --> 00:24:28.563

Or it could be a strategic, we're going to move in this direction,

00:24:28.563 --> 00:24:31.943

we're going to start here, maybe they'll sue us, maybe they won't,

00:24:32.023 --> 00:24:33.143

and we'll see what happens.

00:24:33.583 --> 00:24:40.003

I kind of wonder if when it happened, I kind of wondered if HRSA was afraid of lawsuits.

00:24:40.203 --> 00:24:43.923

So that's why they just kind of went with the manufacturers.

00:24:44.163 --> 00:24:49.803

Which is really unfair because the health center had an argument that this manufacturer

00:24:49.803 --> 00:24:53.363

audit should have never been permitted, should have never been allowed to move forward.

00:24:53.363 --> 00:24:58.723

But to spend six figures to be right, you don't get anything back on that.

00:24:58.723 --> 00:25:01.563

It isn't there's no there's no award at the end of that case.

00:25:01.763 --> 00:25:05.963

You just get her to change what it did. They're not going to do that.

00:25:06.443 --> 00:25:10.103

The manufacturer might. But the health center is probably not going to invest.

00:25:11.183 --> 00:25:14.363

Even if they do, that six figures would be patient care money.

00:25:14.523 --> 00:25:17.623

Yeah. Yeah. It's not sitting in a litigation pool somewhere. Yeah.

00:25:18.243 --> 00:25:24.183

Yeah. So what other lawsuits potentially could we be seeing in the next few months?

00:25:24.343 --> 00:25:29.863

We've seen some startling patient definition audit reports from HRSA.

00:25:30.083 --> 00:25:35.283

And just to set the table, last November, the Genesis case comes out of a federal

00:25:35.283 --> 00:25:36.343

court in South Carolina.

00:25:36.643 --> 00:25:40.743

A judge is finally looking at the way HRSA applies the patient definition and

00:25:40.743 --> 00:25:46.023

basically says, I'm okay with this 1996 guidance, but these other location timing

00:25:46.023 --> 00:25:48.883

requirements that you've added on, they're not obvious from the statute.

00:25:49.563 --> 00:25:54.403

And the hope is, great, now we get to just focus on, do we have a patient relationship?

00:25:54.603 --> 00:25:57.543

And if we do, we can use 340B, and if we don't, we can't.

00:25:57.663 --> 00:26:02.463

But we knew HRSA may or may not adopt that entire mindset, but they were probably

00:26:02.463 --> 00:26:05.203

going to have to go back and change something about the way they were applying

00:26:05.203 --> 00:26:08.203

location tests and referral tests and things like that.

00:26:08.203 --> 00:26:14.643

So we knew we wouldn't really get audit reports for a while because the decision comes out in November.

00:26:15.003 --> 00:26:18.163

If people make changes, it's going to be in December, January,

00:26:18.383 --> 00:26:20.623

February, then they have to get picked for an audit.

00:26:20.803 --> 00:26:23.343

And then the audit has to look at that window from that window.

00:26:23.343 --> 00:26:29.143

March 4th. So we finally started getting some of those come shake out of HRSA in September.

00:26:29.503 --> 00:26:34.143

And we have at least a couple, we've seen probably four, but at least two that

00:26:34.143 --> 00:26:39.963

we've worked on firsthand where there is a clear hospital or health center encounter

00:26:39.963 --> 00:26:41.683

for a specific condition.

00:26:41.843 --> 00:26:47.623

They are referred to a specific provider for a care exactly following up that

00:26:47.623 --> 00:26:51.163

prior condition, full record sharing, HRSA says no.

00:26:51.603 --> 00:26:55.743

If that's not a valid referral prescription, I don't know what is because that's

00:26:55.743 --> 00:26:58.583

been a valid prescription since day one in the 340B program.

00:26:58.823 --> 00:27:03.123

I guess my question in those scenarios is covered entity type taken into effect,

00:27:03.363 --> 00:27:09.123

into account, because I mean, I think an argument could be made that certain

00:27:09.123 --> 00:27:15.003

covered entity types have more of a long-standing relationship with the patient,

00:27:15.143 --> 00:27:16.823

and some are more episodic in nature.

00:27:16.983 --> 00:27:22.323

I would say for these cases, it does not appear that they took into account covered entity type.

00:27:22.723 --> 00:27:26.943

For example, the hospital case, you have someone with hypertensive emergency,

00:27:27.103 --> 00:27:30.143

high blood pressure emergency. They treat them in the emergency room.

00:27:30.203 --> 00:27:31.343

They get admitted for a week.

00:27:31.703 --> 00:27:35.103

The doctor comes and rounds on them, and then they refer the patient to that

00:27:35.103 --> 00:27:39.103

same doctor at their private practice that shares records back with the hospital.

00:27:39.323 --> 00:27:43.403

It's hard to get a tighter length than that between the entire episode of care.

00:27:44.123 --> 00:27:49.223

And then we had a health center that was also part of this batch that had the

00:27:49.223 --> 00:27:54.003

usual many, many, many encounters with the patient, but this one prescription

00:27:54.003 --> 00:27:56.423

was an outside provider that they disallowed.

00:27:56.883 --> 00:28:02.383

And I think if they don't change those audit reports after, for those of you

00:28:02.383 --> 00:28:05.503

who don't know, you get a 340B audit report, you get to challenge it,

00:28:05.583 --> 00:28:06.543

then you'll get a final report.

00:28:06.763 --> 00:28:09.963

If they don't change it before the final report, some of these entities are

00:28:09.963 --> 00:28:14.783

going to sue, and they're going to basically just cite Genesis as the basis for their suit.

00:28:14.983 --> 00:28:19.183

And even though Genesis had that footnote that it only applied to Genesis.

00:28:19.743 --> 00:28:23.083

That's relatively common for. Yeah, that's normal, isn't it?

00:28:23.323 --> 00:28:24.523

Well, it's the same federal law.

00:28:24.883 --> 00:28:28.983

Yeah, well, the language is the same for everybody, right?

00:28:29.343 --> 00:28:33.043

Like, OK, that opinion might have applied to Genesis, but it interpreted the term patient.

00:28:33.557 --> 00:28:37.097

Which is only mentioned once in the 340B statute. And, you know,

00:28:37.177 --> 00:28:40.937

the plain meaning of the term. Miriam does not change based upon the entity type.

00:28:41.297 --> 00:28:47.397

Miriam is Miriam is Miriam. So I don't know why HRSA, other than seeking to

00:28:47.397 --> 00:28:51.277

get another bite at the apple, just for my pharmacist, I'm going to back up, all right?

00:28:51.437 --> 00:28:55.237

So 340B is a pricing and purchasing statute, you know, significant discounts.

00:28:55.577 --> 00:28:59.897

And the term patient's mentioned once, and that's what sets the limitation on what you can purchase.

00:29:00.217 --> 00:29:02.457

If it's your patient, you can purchase. If it's not your patient,

00:29:02.457 --> 00:29:05.837

We're talking about a physician-patient relationship, a provider-patient relationship, right?

00:29:06.057 --> 00:29:09.697

We're not talking about provider-patient relationship for every healthcare service

00:29:09.697 --> 00:29:11.557

that ever happened to this person everywhere in the world.

00:29:11.757 --> 00:29:14.697

You just have to have a relationship with your patient. Simple.

00:29:14.817 --> 00:29:15.637

Did you render a service?

00:29:15.957 --> 00:29:20.497

Well, HRS has taken it, as Jason mentioned, and applying it across the world in every way.

00:29:20.597 --> 00:29:24.417

You have to be responsible for everything that ever happens to this patient

00:29:24.417 --> 00:29:25.917

in order to purchase Dr. 340B.

00:29:26.077 --> 00:29:29.837

And that's just not what the term patient means. It doesn't mean,

00:29:29.997 --> 00:29:32.777

you know, everything that ever happens, you have to be responsible for.

00:29:32.857 --> 00:29:37.697

And I would recommend if you're working in this program that everyone go out and read Genesis.

00:29:38.117 --> 00:29:42.517

Even as a non-lawyer, it's really easy to understand. It was written in a way

00:29:42.517 --> 00:29:43.977

that's very approachable.

00:29:44.177 --> 00:29:48.217

Yeah. And it's 33 pages. There are not dense legal concepts in that.

00:29:48.437 --> 00:29:51.257

I didn't have to Google words like I would have had to today. Exactly.

00:29:51.557 --> 00:29:54.137

Because it really all turns on what does the word patient mean?

00:29:54.217 --> 00:29:57.897

Yeah. What did Congress mean when they used it, you know, 30 years ago?

00:29:58.117 --> 00:30:01.577

Yeah. Well, I have a question. So if you go to your doctor, here's a simple question.

00:30:01.877 --> 00:30:05.457

You got to make this fast, man. We are running out of time here. Well, simple.

00:30:05.557 --> 00:30:08.437

When you go to your primary care doctor and then you've been going to your doctor

00:30:08.437 --> 00:30:11.377

and then you go to another doctor, you decide to get a second opinion.

00:30:11.537 --> 00:30:13.797

Does that mean that primary care doctor is no longer your doctor?

00:30:14.590 --> 00:30:18.070

No, she doesn't say no. She's a patient. Pretty obvious.

00:30:18.350 --> 00:30:21.290

But I think the problem is, because this was congressional intent,

00:30:21.530 --> 00:30:25.350

companies are purchasing a lot of drugs and a person wants to reel that back.

00:30:25.670 --> 00:30:27.330

She doesn't have the authority to do that.

00:30:27.710 --> 00:30:30.990

All right. So knowing that we are running tight on time, I'm going to say final

00:30:30.990 --> 00:30:35.870

thoughts on litigation. It could be existing or what we anticipate seeing.

00:30:36.190 --> 00:30:40.110

I mean, from my side, I would say we're going to see a lot more litigation.

00:30:40.230 --> 00:30:44.090

We're going to see some litigation flow through the administrative dispute resolution

00:30:44.090 --> 00:30:47.770

process and be it brought through HRSA and then to federal court.

00:30:48.010 --> 00:30:54.990

And then we will have to see how a new administration will change policy within

00:30:54.990 --> 00:30:57.090

HHS or within HRSA if they do.

00:30:57.270 --> 00:31:00.170

There may not be much change between one administration to the next,

00:31:00.190 --> 00:31:02.110

or there could be significant change.

00:31:02.310 --> 00:31:05.710

But things like the rebate model and other things, we have to see what happens.

00:31:06.110 --> 00:31:08.650

Yeah, I definitely think we're going to see litigation. I think we're going

00:31:08.650 --> 00:31:11.250

to get a lot of administrative dispute resolution. We're going to get a lot

00:31:11.250 --> 00:31:13.730

of manufacturer audits of covered entities.

00:31:14.110 --> 00:31:17.450

So covered entities, hunker down, get your legal counsel.

00:31:17.910 --> 00:31:22.750

The drug makers will be auditing you. But I do think that all the courts agree

00:31:22.750 --> 00:31:27.410

the plain language dictionary definition of terms in a statute is what prevails.

00:31:27.630 --> 00:31:30.950

So we're getting attacked by the government overbroad.

00:31:31.310 --> 00:31:34.570

We're getting attacked by the drug makers trying to insert language into the

00:31:34.570 --> 00:31:36.830

statute where they want to limit 340B purchases.

00:31:37.370 --> 00:31:41.090

A lot of allegation, but I'm confident that the Covenant needs will defend themselves properly.

00:31:41.350 --> 00:31:46.550

I think it's been a great conversation, and I think we're going to see a lot

00:31:46.550 --> 00:31:52.410

more coming down the road as we're especially changing executive administrations.

00:31:52.730 --> 00:31:56.870

And as you said, Jason, so all of this could change tomorrow.

00:31:57.130 --> 00:32:02.490

So it is a point in time, but it's good from a pharmacist's perspective to hear

00:32:02.490 --> 00:32:08.190

an easy explanation of some of these things that are not in our daily vocabulary.

"I would recommend for anyone working in this program, that you go out and read Genesis. Even as a non-lawyer, it's really easy to understand."

-Logan Yoho

Your Hosts

our team image
Logan Yoho

Meet Logan Yoho, PharmD, BCACP, 340B ACE, and co-host of the 340Banter Podcast. With nearly a decade of experience in the 340B industry, Logan is dedicated to helping health centers optimize and maintain successful, compliant 340B Programs. As Director of Advocacy and Education at FQHC 340B Compliance, he focuses on implementing entity-owned pharmacies and guiding advocacy efforts for 340B. Logan’s extensive background includes leading the pharmacy and 340B programs at Hopewell Health Centers, serving as Apexus 340B University Faculty, and chairing the Ohio 340B FQHC Consortium. Logan’s leadership and expertise have earned him multiple awards, and he brings a wealth of knowledge to every episode of 340Banter.

our team image
Chelsea Violette

Meet Chelsea Violette, PharmD, BCACP, 340B ACE, and your co-host for the 340Banter Podcast. With over a decade of experience in pharmacy and 340B Program management, Chelsea brings a wealth of knowledge to the table. As Chief Operating Officer at FQHC 340B Compliance, she works tirelessly to support health centers across the country, ensuring they have the tools and strategies they need to succeed. Chelsea’s hands-on experience as a 340B Consultant and Pharmacy Manager, combined with her expertise as a subject matter expert for the Apexus 340B Prime Vendor Program, makes her a trusted voice in the world of 340B compliance. Tune in for her practical insights, guidance, and lively discussions on all things 340B.

Want to Read along?

Download the Transcript

00:00:00.017 --> 00:00:05.237

Welcome to the 340 Banter podcast. Today, we're joined by Mark Ogunshusi,

00:00:05.537 --> 00:00:07.697

as well as Jason Reddish from Powers Law.

00:00:08.097 --> 00:00:12.577

We'll be discussing recent legal arguments pharmaceutical manufacturers have

00:00:12.577 --> 00:00:17.677

been using inside the courts, as well as what we see coming down the road in litigation.

00:00:18.357 --> 00:00:22.857

Even though Mark and Jason are lawyers, you should not use this as legal advice

00:00:22.857 --> 00:00:24.617

and should consult general counsel.

00:00:45.157 --> 00:00:49.737

All right. So 340B has been really rampant in the courtrooms lately,

00:00:49.917 --> 00:00:51.737

both at the state and the federal level.

00:00:51.857 --> 00:00:55.237

So I was wondering if we could kind of go through today and get your insights

00:00:55.237 --> 00:00:59.617

from the legal perspective, both of us being pharmacists, and maybe go through

00:00:59.617 --> 00:01:02.937

some of the arguments that have come up in those court cases lately.

00:01:03.617 --> 00:01:06.137

Yeah, I mean, that sounds like a good idea, but we're going to keep it,

00:01:06.157 --> 00:01:08.077

you know, related to pharmacists.

00:01:08.417 --> 00:01:11.657

We're not talking to lawyers, we're talking to pharmacists. It was a lot easier

00:01:11.657 --> 00:01:15.697

when there were only like two 340B cases for the first 30 years to keep track of.

00:01:16.037 --> 00:01:19.097

Oh, yeah. Well, we talked about, you know, going through case by case,

00:01:19.157 --> 00:01:21.317

but we would be here for weeks. So we're going to go back.

00:01:21.557 --> 00:01:23.917

And we would need a lot of paper in front of us, which would not be helpful.

00:01:23.917 --> 00:01:25.237

We'll go by arguments instead at this point.

00:01:25.997 --> 00:01:30.097

So let's kick us off. I think preemption is one of the first ones that had come up.

00:01:30.257 --> 00:01:34.077

You want to talk us kind of through what that is and how that's played out in the court cases so far.

00:01:34.157 --> 00:01:38.137

Yeah. So my pharmacists out there, we're dealing with these state laws that

00:01:38.137 --> 00:01:40.757

require drugs to be shipped to your pharmacies.

00:01:41.677 --> 00:01:46.897

And, you know, the drug makers, manufacturers don't like these state laws because

00:01:46.897 --> 00:01:52.197

they require that these discounted medications that safety net providers provide

00:01:52.197 --> 00:01:53.537

are shipped to your pharmacies.

00:01:53.617 --> 00:01:58.437

And they're saying, no, federal law is the absolute, because 340 is a federal

00:01:58.437 --> 00:02:01.177

pricing statute, right? That's where the price occurs.

00:02:01.437 --> 00:02:04.457

Say it's absolute, leaves no room for state law. So therefore,

00:02:04.737 --> 00:02:06.077

it preempts the state law.

00:02:06.297 --> 00:02:09.577

So any state law relating to delivery, and we all know there's all sorts of

00:02:09.577 --> 00:02:13.377

state laws relating to delivery, wholesaler laws and things of that nature,

00:02:13.517 --> 00:02:15.397

controlled substance laws related to distribution.

00:02:16.585 --> 00:02:21.905

Somehow, spontaneously, a federal pricing statute allegedly preempts or supplants

00:02:21.905 --> 00:02:27.025

or should take the place of or cancels out the state law. And that's preemption.

00:02:27.465 --> 00:02:30.305

So that's the argument. I don't know if you wanted to get into the disposition

00:02:30.305 --> 00:02:35.245

of these cases. So I think we've seen a lot of success at the state level.

00:02:35.485 --> 00:02:39.545

And so obviously that argument is not working.

00:02:39.765 --> 00:02:45.645

Is that what we're seeing? Yeah, at the federal court level,

00:02:45.785 --> 00:02:51.465

but looking at state laws, they've found that the 340B statute doesn't address delivery.

00:02:51.825 --> 00:02:57.345

It addresses pricing and addresses some other aspects of acquiring the drugs,

00:02:57.365 --> 00:03:01.125

but it doesn't speak to whether drugs have to be shipped to a certain place

00:03:01.125 --> 00:03:06.185

or whether manufacturers have to ship to where the covered entity wants them to be shipped.

00:03:06.745 --> 00:03:10.205

So the preemption arguments have largely fallen flat.

00:03:10.725 --> 00:03:14.985

They were also hurt a little bit because on the cases that challenged whether

00:03:14.985 --> 00:03:19.225

manufacturers could impose restrictions on contract pharmacy restrictions,

00:03:19.405 --> 00:03:22.685

their whole argument is, well, there's a huge gap in the statute. It just says offer.

00:03:22.865 --> 00:03:25.905

So we can fill that gap. If there's a huge gap in the statute,

00:03:26.105 --> 00:03:28.985

it obviously doesn't occupy all of the 340B field.

00:03:29.125 --> 00:03:33.605

And there was room for state regulation in areas that states typically regulate shipments.

00:03:33.985 --> 00:03:36.545

I want to add to what Jason's name is. we're talking to pharmacists, right?

00:03:36.985 --> 00:03:40.565

I mean, how complex is the practice of pharmacy? How many variations do we see?

00:03:40.905 --> 00:03:45.245

We see institutional pharmacy at hospitals. We see retail pharmacies.

00:03:45.365 --> 00:03:48.225

We see long-term care pharmacies. We see infusion pharmacies.

00:03:48.785 --> 00:03:52.345

And state laws govern the practice of pharmacy. In fact, Jason,

00:03:52.865 --> 00:03:54.965

does the 340 statute even mention the term pharmacy?

00:03:55.165 --> 00:03:57.225

No, the word pharmacy is not used anywhere. Not once.

00:03:57.565 --> 00:04:00.165

So why are the drug makers saying that the federal law preempts the state law?

00:04:00.285 --> 00:04:04.225

I don't know. I don't know. All right. Well, then we'll move on from preemption.

00:04:05.025 --> 00:04:09.865

Next one we've seen is the Dormant Commerce Clause. I mean, that's a mouthful.

00:04:10.045 --> 00:04:12.165

The Dormant Commerce Clause.

00:04:12.405 --> 00:04:16.565

Long story short, for my pharmacists out there, they believe these state delivery

00:04:16.565 --> 00:04:21.865

laws regulate Honda transactions occurring completely out of the state.

00:04:22.025 --> 00:04:26.905

It's an old constitutional law concept that interstate commerce,

00:04:26.905 --> 00:04:28.585

the federal government can regulate.

00:04:28.785 --> 00:04:33.645

And they're saying that a state law that requires the drug maker to not block

00:04:33.645 --> 00:04:37.545

or limit delivery of these discounted drugs to the pharmacies,

00:04:37.725 --> 00:04:41.085

to your pharmacy, regulates out-of-state conduct.

00:04:41.425 --> 00:04:47.125

You know, the drug makers just spontaneously, after years of delivering drugs into states,

00:04:47.705 --> 00:04:52.405

now states can't regulate these deliveries because some drug makers are located

00:04:52.405 --> 00:04:55.245

in that state, some drug makers are located in that state, but at the end of

00:04:55.245 --> 00:04:57.605

the day, they know their drugs are getting to your state.

00:04:57.985 --> 00:05:02.525

And again, that's another argument that I think is a bit spurious, spurious, spurious,

00:05:03.073 --> 00:05:07.373

You know, I haven't seen a new word for me. Well, it's unreasonable.

00:05:10.693 --> 00:05:15.973

It's well, it's unreasonable. I mean, it's like these are old constitutional

00:05:15.973 --> 00:05:18.493

contentions that have never gone anywhere.

00:05:18.713 --> 00:05:23.793

And there's plenty of case law establishing that states can regulate delivery

00:05:23.793 --> 00:05:25.273

of drugs within their borders. Yeah.

00:05:25.413 --> 00:05:30.073

And so, you know, what we've seen is failure by the drug makers on that.

00:05:30.153 --> 00:05:32.693

In fact, they're dropping those claims, that claim. They're not really even

00:05:32.693 --> 00:05:33.933

included in their litigation.

00:05:34.313 --> 00:05:38.753

And there are plenty of state laws that have impacts on activities outside of the state.

00:05:38.873 --> 00:05:42.513

I mean, one thing I use, I think of often when you're talking about this,

00:05:42.693 --> 00:05:46.033

it's called the Dormant Commerce Clause because the idea is if the federal government

00:05:46.033 --> 00:05:49.353

can regulate commerce between the states, then states can't do anything that

00:05:49.353 --> 00:05:51.013

hinders commerce between states.

00:05:51.093 --> 00:05:53.613

Yeah, that makes sense. But you think about, we watched game shows growing up.

00:05:53.693 --> 00:05:55.693

You've got the California emission standards.

00:05:55.913 --> 00:05:58.453

Like every car was up to the California emission standards.

00:05:58.853 --> 00:06:02.193

They're the biggest market. If they set an emission standard and they're allowed

00:06:02.193 --> 00:06:05.553

to under state law, that's going to affect everybody out of state because they're

00:06:05.553 --> 00:06:08.453

probably going to go down to that standard to be able to ship drugs to,

00:06:08.633 --> 00:06:09.933

I mean, ship cars to California.

00:06:10.553 --> 00:06:14.633

So it's not unusual for a state to have a minimum standard for their own state

00:06:14.633 --> 00:06:17.453

that is going to affect people who want to ship into the state.

00:06:17.453 --> 00:06:21.293

As long as it applies equally to a drug manufacturer in Arkansas as it does

00:06:21.293 --> 00:06:23.733

to one in New York, then there's not really an impact. Yeah,

00:06:23.893 --> 00:06:24.913

that's a great explanation.

00:06:26.218 --> 00:06:29.158

All right. So the next one we've got is due process takings.

00:06:29.358 --> 00:06:34.718

So this is what they're really kind of focusing on lately, which is that,

00:06:34.838 --> 00:06:35.718

you know, the government,

00:06:36.058 --> 00:06:41.238

state or federal government can't take private property from private individuals

00:06:41.238 --> 00:06:43.438

or entities without just compensation.

00:06:43.918 --> 00:06:47.858

And so I mentioned we have this is all about the 340B federal pricing statute.

00:06:47.858 --> 00:06:49.598

That's nothing about delivery or distribution.

00:06:50.118 --> 00:06:55.078

But they're alleging that because the statute sets a price that these coverings

00:06:55.078 --> 00:06:58.658

can pay and the state law says you must deliver it to where the coverings say

00:06:58.658 --> 00:07:01.518

you should deliver it, that that's taking their property.

00:07:01.638 --> 00:07:04.958

They have patents and they should be able to set their prices unreasonably high.

00:07:05.078 --> 00:07:09.058

I'm not going to get crazy, but we know drug makers are 300 to 1,000 percent

00:07:09.058 --> 00:07:11.158

in the United States and the other developed country in the world.

00:07:11.158 --> 00:07:15.458

We know we're being screwed here in the United States, but they're saying that

00:07:15.458 --> 00:07:17.958

that's a taking and that they weren't justly compensated.

00:07:18.598 --> 00:07:21.918

But, you know, the counterargument to that, similar to with the inflation reduction

00:07:21.918 --> 00:07:24.438

for my pharmacist, Medicare negotiated prices,

00:07:25.038 --> 00:07:30.478

discounted Medicare drugs, is that the drug makers voluntarily participate in

00:07:30.478 --> 00:07:34.098

the 340B program so that their drugs are covered under Medicare and Medicaid.

00:07:34.298 --> 00:07:37.658

The business decision at the end of the day. Well, it's a really good business decision.

00:07:38.258 --> 00:07:41.978

How much taxpayer, I mean, how much money do you think these companies are making

00:07:41.978 --> 00:07:45.838

off of Medicare and Medicaid in exchange for giving some safety net providers

00:07:45.838 --> 00:07:48.298

critical discounts to keep our country moving?

00:07:48.738 --> 00:07:54.138

Billions and billions of dollars. Have we seen that actually go through any

00:07:54.138 --> 00:07:58.358

court cases yet? Has it been successful? Actually, on the Inflation Reduction

00:07:58.358 --> 00:08:00.718

Act side, it's been rejected repeatedly.

00:08:00.918 --> 00:08:04.098

The taking cost. And it actually makes a lot more sense on that side,

00:08:04.238 --> 00:08:08.298

where they say, I've got this patent window, and now you're telling me that

00:08:08.298 --> 00:08:13.178

I have to submit to your price, basically, or pay an incredibly high tax.

00:08:14.218 --> 00:08:16.938

And if I don't, my only other option is drop out of Medicare.

00:08:17.398 --> 00:08:19.918

And so they're saying we're being hijacked to do it.

00:08:19.998 --> 00:08:23.838

And the counter argument is Medicare is the biggest drug market in the world.

00:08:24.098 --> 00:08:27.338

It's one of the best payers in the world. If you want access to that market,

00:08:27.498 --> 00:08:28.958

you have to play by that market's rules.

00:08:29.478 --> 00:08:34.298

And for the most part, that is that is largely succeeded and knocked down the

00:08:34.298 --> 00:08:35.278

manufacturer arguments.

00:08:35.578 --> 00:08:40.138

You know, whether the IRA survives a change in in the House or presidency is

00:08:40.138 --> 00:08:44.198

probably a bigger conversation or whether it survives with changes is probably a bigger conversation.

00:08:44.218 --> 00:08:48.178

But the due process arguments have not gotten them over the finish line.

00:08:48.478 --> 00:08:51.218

You can't take what you're voluntarily participating in.

00:08:51.558 --> 00:08:54.938

Yeah, there's an option that the manufacturers could choose to not be part of

00:08:54.938 --> 00:08:58.498

the pharmacy pricing agreement, which would remove them from Medicaid and Medicare,

00:08:58.738 --> 00:09:03.638

but would also remove them from the 340B program. PBM contracts are terrible.

00:09:03.858 --> 00:09:07.698

You could choose not to contract with the major PBMs. You won't be able to run

00:09:07.698 --> 00:09:09.278

a pharmacy, but you could choose that.

00:09:09.578 --> 00:09:13.698

Well, yeah, of course. I think one thing to add on to the PBM situation,

00:09:13.698 --> 00:09:17.518

if I'm a pharmacy, is that I'm not, by signing this PBM contract,

00:09:17.658 --> 00:09:20.658

making billions and billions of taxpayer dollars.

00:09:20.978 --> 00:09:25.038

I mean, these drug companies are making massive amounts by, you know,

00:09:25.178 --> 00:09:28.858

participating in the 340B program because their drugs are covered under a separate

00:09:28.858 --> 00:09:32.598

program, Medicare, Medicaid, and other programs. I mean, they're killing it.

00:09:32.698 --> 00:09:35.778

I mean, I mean, anyways, I'm not going to get into it. They make a lot of money.

00:09:35.858 --> 00:09:36.698

Let's just put it that way.

00:09:37.438 --> 00:09:40.338

Really? I didn't get that message. They're doing okay. Stop punching down.

00:09:40.658 --> 00:09:44.958

Okay. All right. So we'll move on to the contracts clause. The next one we're seeing.

00:09:45.478 --> 00:09:48.918

Yeah, this one's pretty simple. The drug makers are saying, you know,

00:09:49.058 --> 00:09:52.078

by requiring us to deliver drugs to where the patients can actually pick them

00:09:52.078 --> 00:09:57.058

up, you're modifying our contracts with, let's say, wholesalers or other contracts that they have.

00:09:57.358 --> 00:10:02.978

And, you know, again, none of these claims have won in any federal court. You know, they're.

00:10:03.533 --> 00:10:09.653

Untenable propositions that, you know, really would upset decades-long practice.

00:10:09.953 --> 00:10:11.433

You know, there's plenty of regulations

00:10:11.433 --> 00:10:13.833

on it. Let's talk about state-controlled substance laws, right?

00:10:14.073 --> 00:10:18.313

That modifies a wholesaler contract. You know, there's plenty of state laws

00:10:18.313 --> 00:10:21.113

that have impacts on your contracts.

00:10:21.233 --> 00:10:25.473

The bottom line is states are free to protect public health and safety within their borders.

00:10:25.793 --> 00:10:31.073

And, you know, I hope the drug makers get with the public health program and

00:10:31.073 --> 00:10:32.833

stop these spurious arguments.

00:10:33.473 --> 00:10:36.533

Yeah, I mean, contracts clause is a tough thing to argue. Basically,

00:10:36.613 --> 00:10:40.653

there's a line in the Constitution that says no state shall impair the obligation of contracts.

00:10:40.973 --> 00:10:45.393

But that could be like, I'm going to pass a law that says Logan Yoho doesn't

00:10:45.393 --> 00:10:49.133

owe his mortgage to that bank in Ohio anymore. You're lucky that. Yeah.

00:10:51.033 --> 00:10:55.753

It's not, there are a lot of exceptions in balancing tests when you're imposing

00:10:55.753 --> 00:11:00.673

regulations that help health and safety that happen to have an impact on existing contracts.

00:11:00.933 --> 00:11:04.593

So one of the things I like about talking through these arguments and explaining

00:11:04.593 --> 00:11:10.053

them to somebody that's not a lawyer is that what we're seeing is that in some

00:11:10.053 --> 00:11:13.133

states they're considering this, but there's fears of this litigation.

00:11:13.133 --> 00:11:18.673

So it's really good that we're discussing this and showing that these arguments

00:11:18.673 --> 00:11:19.593

haven't been successful.

00:11:19.813 --> 00:11:23.533

I think there's value there. And we went from Louisiana, I mean,

00:11:23.553 --> 00:11:28.953

Arkansas to Arkansas and Louisiana to Arkansas, Louisiana, Maryland,

00:11:29.053 --> 00:11:34.133

Mississippi, Missouri, Minnesota, Kansas, West Virginia in like three and a half, four years.

00:11:34.293 --> 00:11:38.433

And there were probably another five or six states that there was fear.

00:11:38.633 --> 00:11:41.873

Well, we don't want to get sued or we're afraid that we'll get pulled into this litigation.

00:11:42.213 --> 00:11:47.333

Every time one of these states wins, it makes it easier and easier to pass a law in another state.

00:11:47.513 --> 00:11:50.933

So maybe we go from eight now to 15 next year. Yeah.

00:11:51.493 --> 00:11:55.053

Especially if there's fear about what's going to happen at the federal level.

00:11:55.213 --> 00:11:59.013

Yeah, I think that could play in as a positive at the state level.

00:11:59.133 --> 00:12:01.653

Yeah, when you read the opinions, the judges aren't even...

00:12:02.498 --> 00:12:05.278

I mean, they're duly considering the drug maker's arguments,

00:12:05.278 --> 00:12:09.098

but they're, you know, they're slapping them down back and forth.

00:12:09.338 --> 00:12:13.418

So really, we're just talking about multinational, highly profitable companies

00:12:13.418 --> 00:12:14.638

that have the money to sue,

00:12:14.918 --> 00:12:18.518

to slow down enforcement against them so that they continue to drive up shareholder

00:12:18.518 --> 00:12:21.598

value and make more money, money, money, money on the backs of our community

00:12:21.598 --> 00:12:24.278

pharmacies, on the backs of our patients who are in underserved communities,

00:12:24.458 --> 00:12:28.898

on the backs of our safety net providers and public health providers throughout the country. Yeah.

00:12:29.178 --> 00:12:32.238

I'm going to take us to an argument that's not a constitutional argument,

00:12:32.358 --> 00:12:37.738

but one we're seeing come up, I think, a lot more recently is the kind of questioning

00:12:37.738 --> 00:12:40.158

the replenishment system and maintaining the title of the drug.

00:12:40.758 --> 00:12:44.418

Yeah, so that fits within a constitutional argument. It fits within,

00:12:44.578 --> 00:12:48.238

you know, AstraZeneca is alleging that in Arkansas, for example.

00:12:48.498 --> 00:12:52.658

But it fits within the due process takings, like taking property without just

00:12:52.658 --> 00:12:54.098

compensation, like patented property.

00:12:54.358 --> 00:12:57.838

And it fits within the preemption. They're saying that the 340 statute says

00:12:57.838 --> 00:13:01.698

a covered entity, the safety net provider who's entitled to purchase the drug,

00:13:01.858 --> 00:13:06.098

shall not transfer the drug to anyone other than a person, a patient,

00:13:06.258 --> 00:13:07.398

a patient of the covered entity.

00:13:07.558 --> 00:13:09.818

Yes. Right. Which has been around since the beginning of time.

00:13:10.158 --> 00:13:14.318

So the drug makers are saying replenishment, you know, where the drug is dispensed,

00:13:14.598 --> 00:13:19.098

a drug is dispensed, and a drug replenishes the drug, that's all I'm going to say about it,

00:13:19.458 --> 00:13:22.938

violates the transfer prohibition, and it's a taking of their property,

00:13:23.038 --> 00:13:25.438

their discounted drugs. Now, let's just think about it.

00:13:26.642 --> 00:13:29.502

Replenishment it's just an inventory accounting system first in

00:13:29.502 --> 00:13:32.362

first out yada yada has been around since before

00:13:32.362 --> 00:13:35.662

establishment of the united states it's well established

00:13:35.662 --> 00:13:38.642

that when a party is

00:13:38.642 --> 00:13:44.182

has some inventory especially fungible goods you know you don't have to account

00:13:44.182 --> 00:13:48.522

with detailed particularity one product versus another product they're fungible

00:13:48.522 --> 00:13:51.602

they're inter place they're interchangeable for example when i put money into

00:13:51.602 --> 00:13:55.642

the bank and the bank mixes that money up with all the other money in the bank.

00:13:55.782 --> 00:13:57.862

That doesn't mean the bank automatically owns your money.

00:13:58.302 --> 00:14:01.442

The bank is just holding that money on your behalf. You're also not getting

00:14:01.442 --> 00:14:04.162

the exact same, you know, dollar bill back.

00:14:04.622 --> 00:14:07.442

Yeah, you're not getting the serial number. Yeah. Well, yeah.

00:14:07.602 --> 00:14:09.822

And look, I'm not going to get into the legal arguments, but at the end of the

00:14:09.822 --> 00:14:14.902

day, and Jason probably wants to talk more about this, after decades-long practice,

00:14:15.022 --> 00:14:17.342

replenishment systems were used before 340B was enacted.

00:14:17.642 --> 00:14:22.942

Under Nonprofit Institution Act, for example, for, you know, own-use hospitals.

00:14:23.542 --> 00:14:28.082

You know, the thing is, is that after 30 years of practice or more,

00:14:28.342 --> 00:14:32.142

these drug companies are now all of a sudden saying, you know,

00:14:32.262 --> 00:14:34.642

we've been dealing with this, this has been going on.

00:14:34.942 --> 00:14:38.622

It's even more accurate than physically separating the product because you trace

00:14:38.622 --> 00:14:40.622

each drug on an 11-digit.

00:14:40.722 --> 00:14:44.122

Every pill that goes out, you make sure that went to a patient, right?

00:14:44.362 --> 00:14:47.982

They're saying that now it's illegal. Just so you can understand how we feel

00:14:47.982 --> 00:14:51.142

in the covered in the community after 30 years, all of a sudden,

00:14:51.222 --> 00:14:53.642

oh, no, that's illegal. No, you guys are taking my property.

00:14:54.282 --> 00:14:58.922

And actually, it's a good segue into everything that manufacturers are looking

00:14:58.922 --> 00:15:00.902

at that maybe they haven't challenged before.

00:15:01.182 --> 00:15:05.362

A lot of people don't know that pharma filed suit against HRSA in 1996 when

00:15:05.362 --> 00:15:08.782

the first contract pharmacy guidance came out and they actually pulled it back

00:15:08.782 --> 00:15:10.782

because of pushback from Ryan White Clinics.

00:15:11.500 --> 00:15:16.340

So, you know, they were they had an opportunity when this was announced in 1996

00:15:16.340 --> 00:15:20.660

to litigate it and fight over whether the program allowed contract pharmacies.

00:15:20.860 --> 00:15:26.000

They didn't. Now they come back literally 24 years later and they start self-imposing

00:15:26.000 --> 00:15:27.500

some restrictions on the program.

00:15:27.700 --> 00:15:33.260

Does that impact their, I don't know, have a leg to stand on when you're making

00:15:33.260 --> 00:15:36.440

that argument when you've not challenged it for 25 years?

00:15:36.440 --> 00:15:40.420

There is a legal concept. It's called latches, which literally means you delayed

00:15:40.420 --> 00:15:43.900

so long that it's unfair to the person that you're trying to enforce it against.

00:15:44.100 --> 00:15:47.880

It doesn't apply as often when you're dealing with challenging a government

00:15:47.880 --> 00:15:49.800

aspect, but it is a factor.

00:15:49.980 --> 00:15:53.220

I mean, that you voluntarily participated in this model.

00:15:53.480 --> 00:15:58.880

You knew who you were shipping the drugs to for 20 years and you didn't balk at it then.

00:15:59.500 --> 00:16:02.680

But manufacturers are trying to challenge the replenishment model.

00:16:02.680 --> 00:16:07.440

If you think about risk-reward for them, if they were somehow able to get rid

00:16:07.440 --> 00:16:11.140

of replenishment, you would cut the contract pharmacy market in half.

00:16:11.320 --> 00:16:13.700

You would have problems with hospitals and split billing.

00:16:13.980 --> 00:16:17.820

Yeah, hospitals wouldn't be able to manage their clinic-administered or physician-administered

00:16:17.820 --> 00:16:20.460

drugs. They would have to severely limit where they can use 340B.

00:16:20.580 --> 00:16:23.160

And a lot of health centers, even their entity-owned pharmacies,

00:16:23.160 --> 00:16:26.640

are virtual in nature. Depending on Medicaid carve-out and things like that,

00:16:26.700 --> 00:16:29.900

you may have single neutral inventory there.

00:16:30.100 --> 00:16:36.320

Yeah. So you're talking about maybe cutting the volume of 340B purchasing nationwide by $30 billion.

00:16:36.940 --> 00:16:41.660

And they're going to spend some money to try that. And it's not for the purpose. Let's just be clear.

00:16:42.100 --> 00:16:47.040

It's not for the purpose of greater, you know, we don't want this because it'll

00:16:47.040 --> 00:16:51.300

be more accurate if you maintain a separate inventory. Because the second you

00:16:51.300 --> 00:16:55.080

dispense a drug out of a physically separate inventory to a non-patient,

00:16:55.300 --> 00:16:56.700

that's diversion, right?

00:16:56.820 --> 00:17:01.500

There's no opportunity to true up. There's no opportunity to account for the

00:17:01.500 --> 00:17:03.440

pills that are fungible, that are mixable.

00:17:03.800 --> 00:17:07.420

So it really is just an opportunity to do what Jason is saying,

00:17:07.980 --> 00:17:08.780

challenging replenishment.

00:17:09.000 --> 00:17:14.140

It's just to save money. It's just to make money. It's just a multinational profit.

00:17:14.440 --> 00:17:18.060

Or to make things more complicated to the point that you can no longer comply.

00:17:18.300 --> 00:17:24.240

And therefore, you can charge your extremely 300 to 1,000% high list price drugs. Yeah. Anyways.

00:17:24.620 --> 00:17:27.740

All right. Right. So I've got one more constitutional argument for us to hit

00:17:27.740 --> 00:17:32.860

on that's been seen in some of the cases we've seen so far, but seems to be less frequent now.

00:17:33.700 --> 00:17:37.320

Unconstitutional vagueness, which sounds to me just pretty, pretty vague.

00:17:37.520 --> 00:17:40.760

Like it seems like it's pretty self-explanatory. story yeah yeah

00:17:40.760 --> 00:17:43.420

the bottom line is if you're going to

00:17:43.420 --> 00:17:46.340

punish somebody for violating a law they have to know what they're

00:17:46.340 --> 00:17:50.820

prohibited from doing so you know if you have a law in the books that says anybody

00:17:50.820 --> 00:17:56.060

who is is performing vagrancy will be charged with a misdemeanor and you ask

00:17:56.060 --> 00:17:59.200

somebody what is vagrancy and they come up with whatever decision they whatever

00:17:59.200 --> 00:18:02.320

definition they want that's going to be unconstitutionally vague can't create

00:18:02.320 --> 00:18:03.740

a criminal record for someone because.

00:18:06.126 --> 00:18:11.826

Manufacturers have tried to argue that some of the language in these state statutes

00:18:11.826 --> 00:18:14.246

is unconstitutionally vague.

00:18:14.466 --> 00:18:17.426

And I think they've been shut out. I know they've been shut out on those.

00:18:17.546 --> 00:18:20.046

And I think they've stopped really raising that argument.

00:18:20.386 --> 00:18:23.626

Yeah, I think they've stopped raising the argument. If you want an opinion,

00:18:23.766 --> 00:18:28.806

you can look at the Louisiana lawsuits, plural with Pharma and AstraZeneca,

00:18:29.166 --> 00:18:32.486

that they lost with flying colors because the law is pretty clear.

00:18:33.026 --> 00:18:36.426

But unconstitutional vagueness, I mean, a law that says you must not limit delivery

00:18:36.426 --> 00:18:38.046

of a product is pretty concrete.

00:18:38.226 --> 00:18:41.966

I mean, what they want you to do, what they want to do is obfuscate very clear

00:18:41.966 --> 00:18:47.326

laws such that they can create grounds to invalidate them and make more money.

00:18:47.486 --> 00:18:49.506

But at the end of the day, don't limit delivery.

00:18:49.706 --> 00:18:54.406

Your policy specifically references distribution and limiting distribution and

00:18:54.406 --> 00:18:55.426

or prohibiting distribution.

00:18:55.926 --> 00:19:00.066

And that's pretty concrete. And that's why the unconstitutional vagueness argument

00:19:00.066 --> 00:19:03.626

has not, you know, it doesn't have legs. It hasn't had any legs.

00:19:03.926 --> 00:19:08.226

Courts basically have said, you know, under basic case law, we can read the

00:19:08.226 --> 00:19:10.646

statute in a way that's concrete. Right.

00:19:10.846 --> 00:19:13.766

I mean, if you're writing statutes for a state, if you're helping work on a

00:19:13.766 --> 00:19:16.286

bill for your state, you can have it in the back of your mind.

00:19:16.306 --> 00:19:20.406

But the Legislative Council, one of their jobs when they prepare a bill for

00:19:20.406 --> 00:19:23.766

the state is to look for constitutional issues. And that's always going to be

00:19:23.766 --> 00:19:24.606

something they look for.

00:19:24.806 --> 00:19:28.506

So it's already gone through a layer before it gets passed of somebody deciding

00:19:28.506 --> 00:19:30.066

it's not vague. All right.

00:19:30.226 --> 00:19:33.906

So now I kind of want to pivot. And we've talked about the arguments that we've

00:19:33.906 --> 00:19:38.566

seen that are going on in the courtroom right now or have been and say,

00:19:38.726 --> 00:19:41.006

looking forward, what what can we expect?

00:19:41.146 --> 00:19:43.866

Are we going to see some, you know, a lot of the same arguments,

00:19:44.026 --> 00:19:48.206

a lot of the same issues? Are we going to see some new issues coming up? I think new issues.

00:19:48.466 --> 00:19:52.366

So two things that we've been dealing with, and really one of them is now a

00:19:52.366 --> 00:19:57.346

year old, is manufacturers, at least one manufacturer, seeking and obtaining

00:19:57.346 --> 00:20:03.106

permission from HRSA to audit a health center for Medicaid managed care duplicate discounts. Yeah.

00:20:05.559 --> 00:20:09.999

More than a decade, Hearst has said, we don't have any jurisdiction over managed care.

00:20:10.319 --> 00:20:12.759

We're not going to issue. At one point, they said, we're going to issue policy

00:20:12.759 --> 00:20:15.959

in conjunction with CMS on managed care. Then they came back and said, no, we're not.

00:20:16.339 --> 00:20:20.059

Just kidding. Yeah. And the statute itself is written in a way that treats fee-for-service

00:20:20.059 --> 00:20:21.219

differently than managed care.

00:20:21.539 --> 00:20:25.659

When they expanded the rebate program to include managed care in 2010,

00:20:25.979 --> 00:20:29.579

they included a provision that said if the drug's purchased on a 340B account

00:20:29.579 --> 00:20:32.899

and billed to a managed care plan, it's not eligible for a rebate.

00:20:33.099 --> 00:20:37.019

We're only prohibited from billing Medicaid for drugs that are eligible for a rebate.

00:20:37.279 --> 00:20:40.159

So they kind of took it all away from 340B and HRSA.

00:20:40.559 --> 00:20:43.579

It was a big shock. We fought pretty hard.

00:20:43.879 --> 00:20:48.619

HRSA did not relent. They allowed this manufacturer to audit the covered entity.

00:20:48.799 --> 00:20:53.019

The audit actually took place about seven months ago. We still don't have a response.

00:20:53.219 --> 00:20:57.679

They rode this health center hard to make them submit documents and move along.

00:20:57.819 --> 00:21:03.059

And we're not really sure why suddenly HRSA, which has never issued any position

00:21:03.059 --> 00:21:07.739

of its own on managed care, is now letting a drug manufacturer essentially make up the rules.

00:21:08.079 --> 00:21:12.059

Because if there's no rule from HRSA to look at, what rule is the manufacturer?

00:21:12.199 --> 00:21:19.679

And a lot of states have very vague language on how to prevent a rebate in the MCO space.

00:21:19.679 --> 00:21:24.119

Yeah. In this particular case, during the time period, there was no rule for

00:21:24.119 --> 00:21:27.759

managed care claims at the state level and none at the payer level either.

00:21:27.759 --> 00:21:29.719

So I have two follow-ups with that, right?

00:21:29.819 --> 00:21:34.519

So you're saying that's a potential dispute in the future, maybe against HRSA

00:21:34.519 --> 00:21:38.619

for permitting the audit by the drugmaker in the first instance,

00:21:38.699 --> 00:21:41.979

or even obligating the covered entity in any way to be involved in something

00:21:41.979 --> 00:21:42.799

that's not responsible for.

00:21:42.799 --> 00:21:45.639

So my question is, who is responsible?

00:21:45.859 --> 00:21:48.779

So firstly, what you just said made it seem to me, and correct me if I'm wrong.

00:21:49.299 --> 00:21:54.979

That once a covered entity chooses to purchase a 340B drug, the rebateability

00:21:54.979 --> 00:21:57.219

of the drug is extinguished.

00:21:57.339 --> 00:22:01.899

So therefore, the state can't request a rebate once the covered entity chooses to purchase the drug.

00:22:01.959 --> 00:22:06.879

Is that right? Well, the state can write laws and impose rules on when a 340B

00:22:06.879 --> 00:22:09.419

entity can use 340B drugs to bill MCOs.

00:22:09.559 --> 00:22:13.259

They can do that through their contracts with the MCOs and tell the MCOs,

00:22:13.339 --> 00:22:16.779

you're going to tell pharmacies they cannot use 340B drugs.

00:22:16.799 --> 00:22:21.819

Or they can issue a statewide regulation or even pass a law that says you can't

00:22:21.819 --> 00:22:25.359

use 340B drugs when you bill managed care. A lot of states haven't done anything.

00:22:26.238 --> 00:22:31.038

There's nothing on the books about how to do it. And you look at each MCO contract

00:22:31.038 --> 00:22:32.918

or manual and there's nothing there.

00:22:33.078 --> 00:22:37.218

It's so hard to find information. I know we work with health centers all over

00:22:37.218 --> 00:22:43.098

the country to find information about even what MCOs, what PBM they're using.

00:22:43.598 --> 00:22:48.278

And sometimes you find a bulletin and it's just posted on a website somewhere.

00:22:48.518 --> 00:22:53.378

And the lawyer will say, this tears up all of my managed care contracts,

00:22:53.378 --> 00:22:56.378

this bulletin that they just posted. There's no notice and comment.

00:22:56.638 --> 00:23:01.058

There was no official process. They just put a notice on the website and now

00:23:01.058 --> 00:23:04.478

I'm supposed to give up $5 million in managed care bill.

00:23:04.618 --> 00:23:08.078

I mean, it hasn't been handled well in many states.

00:23:08.318 --> 00:23:12.118

Some states have, but in many states it was pretty much ignored.

00:23:12.378 --> 00:23:14.938

And then it got to be a bigger problem for manufacturers.

00:23:15.258 --> 00:23:18.278

And I think HRSA doesn't really know what to do at this point.

00:23:18.278 --> 00:23:22.698

Well, so my question is around the manufacturer audit in HRSA,

00:23:22.878 --> 00:23:26.038

I guess it could be looked at one of two ways.

00:23:26.158 --> 00:23:31.518

Either, you know, condoned it or didn't present a strong front to it.

00:23:31.878 --> 00:23:38.338

Is the timing of kind of Chevron deference in HRSA having less of a say,

00:23:38.798 --> 00:23:41.338

potentially, you know, playing into that?

00:23:41.338 --> 00:23:45.678

I mean, this is actually an area where they have some statutory cover,

00:23:45.838 --> 00:23:50.338

where the statute says that they can, manufacturers can audit under the basically

00:23:50.338 --> 00:23:53.538

conditions that the secretary, which is HRSA, allows.

00:23:53.798 --> 00:23:58.178

So they actually had a little bit of strength here where they put out a policy

00:23:58.178 --> 00:24:01.338

in accordance with notice and comment that may actually have some...

00:24:02.283 --> 00:24:07.163

Some legal effect. Now, somebody else could look at it now, post-Chevron means

00:24:07.163 --> 00:24:10.263

a judge could look at it and reach their own interpretation of what that means.

00:24:10.763 --> 00:24:15.763

But I think this, it could have been a political call that, you know,

00:24:15.903 --> 00:24:21.103

this manufacturer has been beat up pretty bad by HHS on the IRA and some other

00:24:21.103 --> 00:24:22.603

things, so let's let them have this.

00:24:22.843 --> 00:24:24.963

It could have just been a poor decision.

00:24:25.303 --> 00:24:28.563

Or it could be a strategic, we're going to move in this direction,

00:24:28.563 --> 00:24:31.943

we're going to start here, maybe they'll sue us, maybe they won't,

00:24:32.023 --> 00:24:33.143

and we'll see what happens.

00:24:33.583 --> 00:24:40.003

I kind of wonder if when it happened, I kind of wondered if HRSA was afraid of lawsuits.

00:24:40.203 --> 00:24:43.923

So that's why they just kind of went with the manufacturers.

00:24:44.163 --> 00:24:49.803

Which is really unfair because the health center had an argument that this manufacturer

00:24:49.803 --> 00:24:53.363

audit should have never been permitted, should have never been allowed to move forward.

00:24:53.363 --> 00:24:58.723

But to spend six figures to be right, you don't get anything back on that.

00:24:58.723 --> 00:25:01.563

It isn't there's no there's no award at the end of that case.

00:25:01.763 --> 00:25:05.963

You just get her to change what it did. They're not going to do that.

00:25:06.443 --> 00:25:10.103

The manufacturer might. But the health center is probably not going to invest.

00:25:11.183 --> 00:25:14.363

Even if they do, that six figures would be patient care money.

00:25:14.523 --> 00:25:17.623

Yeah. Yeah. It's not sitting in a litigation pool somewhere. Yeah.

00:25:18.243 --> 00:25:24.183

Yeah. So what other lawsuits potentially could we be seeing in the next few months?

00:25:24.343 --> 00:25:29.863

We've seen some startling patient definition audit reports from HRSA.

00:25:30.083 --> 00:25:35.283

And just to set the table, last November, the Genesis case comes out of a federal

00:25:35.283 --> 00:25:36.343

court in South Carolina.

00:25:36.643 --> 00:25:40.743

A judge is finally looking at the way HRSA applies the patient definition and

00:25:40.743 --> 00:25:46.023

basically says, I'm okay with this 1996 guidance, but these other location timing

00:25:46.023 --> 00:25:48.883

requirements that you've added on, they're not obvious from the statute.

00:25:49.563 --> 00:25:54.403

And the hope is, great, now we get to just focus on, do we have a patient relationship?

00:25:54.603 --> 00:25:57.543

And if we do, we can use 340B, and if we don't, we can't.

00:25:57.663 --> 00:26:02.463

But we knew HRSA may or may not adopt that entire mindset, but they were probably

00:26:02.463 --> 00:26:05.203

going to have to go back and change something about the way they were applying

00:26:05.203 --> 00:26:08.203

location tests and referral tests and things like that.

00:26:08.203 --> 00:26:14.643

So we knew we wouldn't really get audit reports for a while because the decision comes out in November.

00:26:15.003 --> 00:26:18.163

If people make changes, it's going to be in December, January,

00:26:18.383 --> 00:26:20.623

February, then they have to get picked for an audit.

00:26:20.803 --> 00:26:23.343

And then the audit has to look at that window from that window.

00:26:23.343 --> 00:26:29.143

March 4th. So we finally started getting some of those come shake out of HRSA in September.

00:26:29.503 --> 00:26:34.143

And we have at least a couple, we've seen probably four, but at least two that

00:26:34.143 --> 00:26:39.963

we've worked on firsthand where there is a clear hospital or health center encounter

00:26:39.963 --> 00:26:41.683

for a specific condition.

00:26:41.843 --> 00:26:47.623

They are referred to a specific provider for a care exactly following up that

00:26:47.623 --> 00:26:51.163

prior condition, full record sharing, HRSA says no.

00:26:51.603 --> 00:26:55.743

If that's not a valid referral prescription, I don't know what is because that's

00:26:55.743 --> 00:26:58.583

been a valid prescription since day one in the 340B program.

00:26:58.823 --> 00:27:03.123

I guess my question in those scenarios is covered entity type taken into effect,

00:27:03.363 --> 00:27:09.123

into account, because I mean, I think an argument could be made that certain

00:27:09.123 --> 00:27:15.003

covered entity types have more of a long-standing relationship with the patient,

00:27:15.143 --> 00:27:16.823

and some are more episodic in nature.

00:27:16.983 --> 00:27:22.323

I would say for these cases, it does not appear that they took into account covered entity type.

00:27:22.723 --> 00:27:26.943

For example, the hospital case, you have someone with hypertensive emergency,

00:27:27.103 --> 00:27:30.143

high blood pressure emergency. They treat them in the emergency room.

00:27:30.203 --> 00:27:31.343

They get admitted for a week.

00:27:31.703 --> 00:27:35.103

The doctor comes and rounds on them, and then they refer the patient to that

00:27:35.103 --> 00:27:39.103

same doctor at their private practice that shares records back with the hospital.

00:27:39.323 --> 00:27:43.403

It's hard to get a tighter length than that between the entire episode of care.

00:27:44.123 --> 00:27:49.223

And then we had a health center that was also part of this batch that had the

00:27:49.223 --> 00:27:54.003

usual many, many, many encounters with the patient, but this one prescription

00:27:54.003 --> 00:27:56.423

was an outside provider that they disallowed.

00:27:56.883 --> 00:28:02.383

And I think if they don't change those audit reports after, for those of you

00:28:02.383 --> 00:28:05.503

who don't know, you get a 340B audit report, you get to challenge it,

00:28:05.583 --> 00:28:06.543

then you'll get a final report.

00:28:06.763 --> 00:28:09.963

If they don't change it before the final report, some of these entities are

00:28:09.963 --> 00:28:14.783

going to sue, and they're going to basically just cite Genesis as the basis for their suit.

00:28:14.983 --> 00:28:19.183

And even though Genesis had that footnote that it only applied to Genesis.

00:28:19.743 --> 00:28:23.083

That's relatively common for. Yeah, that's normal, isn't it?

00:28:23.323 --> 00:28:24.523

Well, it's the same federal law.

00:28:24.883 --> 00:28:28.983

Yeah, well, the language is the same for everybody, right?

00:28:29.343 --> 00:28:33.043

Like, OK, that opinion might have applied to Genesis, but it interpreted the term patient.

00:28:33.557 --> 00:28:37.097

Which is only mentioned once in the 340B statute. And, you know,

00:28:37.177 --> 00:28:40.937

the plain meaning of the term. Miriam does not change based upon the entity type.

00:28:41.297 --> 00:28:47.397

Miriam is Miriam is Miriam. So I don't know why HRSA, other than seeking to

00:28:47.397 --> 00:28:51.277

get another bite at the apple, just for my pharmacist, I'm going to back up, all right?

00:28:51.437 --> 00:28:55.237

So 340B is a pricing and purchasing statute, you know, significant discounts.

00:28:55.577 --> 00:28:59.897

And the term patient's mentioned once, and that's what sets the limitation on what you can purchase.

00:29:00.217 --> 00:29:02.457

If it's your patient, you can purchase. If it's not your patient,

00:29:02.457 --> 00:29:05.837

We're talking about a physician-patient relationship, a provider-patient relationship, right?

00:29:06.057 --> 00:29:09.697

We're not talking about provider-patient relationship for every healthcare service

00:29:09.697 --> 00:29:11.557

that ever happened to this person everywhere in the world.

00:29:11.757 --> 00:29:14.697

You just have to have a relationship with your patient. Simple.

00:29:14.817 --> 00:29:15.637

Did you render a service?

00:29:15.957 --> 00:29:20.497

Well, HRS has taken it, as Jason mentioned, and applying it across the world in every way.

00:29:20.597 --> 00:29:24.417

You have to be responsible for everything that ever happens to this patient

00:29:24.417 --> 00:29:25.917

in order to purchase Dr. 340B.

00:29:26.077 --> 00:29:29.837

And that's just not what the term patient means. It doesn't mean,

00:29:29.997 --> 00:29:32.777

you know, everything that ever happens, you have to be responsible for.

00:29:32.857 --> 00:29:37.697

And I would recommend if you're working in this program that everyone go out and read Genesis.

00:29:38.117 --> 00:29:42.517

Even as a non-lawyer, it's really easy to understand. It was written in a way

00:29:42.517 --> 00:29:43.977

that's very approachable.

00:29:44.177 --> 00:29:48.217

Yeah. And it's 33 pages. There are not dense legal concepts in that.

00:29:48.437 --> 00:29:51.257

I didn't have to Google words like I would have had to today. Exactly.

00:29:51.557 --> 00:29:54.137

Because it really all turns on what does the word patient mean?

00:29:54.217 --> 00:29:57.897

Yeah. What did Congress mean when they used it, you know, 30 years ago?

00:29:58.117 --> 00:30:01.577

Yeah. Well, I have a question. So if you go to your doctor, here's a simple question.

00:30:01.877 --> 00:30:05.457

You got to make this fast, man. We are running out of time here. Well, simple.

00:30:05.557 --> 00:30:08.437

When you go to your primary care doctor and then you've been going to your doctor

00:30:08.437 --> 00:30:11.377

and then you go to another doctor, you decide to get a second opinion.

00:30:11.537 --> 00:30:13.797

Does that mean that primary care doctor is no longer your doctor?

00:30:14.590 --> 00:30:18.070

No, she doesn't say no. She's a patient. Pretty obvious.

00:30:18.350 --> 00:30:21.290

But I think the problem is, because this was congressional intent,

00:30:21.530 --> 00:30:25.350

companies are purchasing a lot of drugs and a person wants to reel that back.

00:30:25.670 --> 00:30:27.330

She doesn't have the authority to do that.

00:30:27.710 --> 00:30:30.990

All right. So knowing that we are running tight on time, I'm going to say final

00:30:30.990 --> 00:30:35.870

thoughts on litigation. It could be existing or what we anticipate seeing.

00:30:36.190 --> 00:30:40.110

I mean, from my side, I would say we're going to see a lot more litigation.

00:30:40.230 --> 00:30:44.090

We're going to see some litigation flow through the administrative dispute resolution

00:30:44.090 --> 00:30:47.770

process and be it brought through HRSA and then to federal court.

00:30:48.010 --> 00:30:54.990

And then we will have to see how a new administration will change policy within

00:30:54.990 --> 00:30:57.090

HHS or within HRSA if they do.

00:30:57.270 --> 00:31:00.170

There may not be much change between one administration to the next,

00:31:00.190 --> 00:31:02.110

or there could be significant change.

00:31:02.310 --> 00:31:05.710

But things like the rebate model and other things, we have to see what happens.

00:31:06.110 --> 00:31:08.650

Yeah, I definitely think we're going to see litigation. I think we're going

00:31:08.650 --> 00:31:11.250

to get a lot of administrative dispute resolution. We're going to get a lot

00:31:11.250 --> 00:31:13.730

of manufacturer audits of covered entities.

00:31:14.110 --> 00:31:17.450

So covered entities, hunker down, get your legal counsel.

00:31:17.910 --> 00:31:22.750

The drug makers will be auditing you. But I do think that all the courts agree

00:31:22.750 --> 00:31:27.410

the plain language dictionary definition of terms in a statute is what prevails.

00:31:27.630 --> 00:31:30.950

So we're getting attacked by the government overbroad.

00:31:31.310 --> 00:31:34.570

We're getting attacked by the drug makers trying to insert language into the

00:31:34.570 --> 00:31:36.830

statute where they want to limit 340B purchases.

00:31:37.370 --> 00:31:41.090

A lot of allegation, but I'm confident that the Covenant needs will defend themselves properly.

00:31:41.350 --> 00:31:46.550

I think it's been a great conversation, and I think we're going to see a lot

00:31:46.550 --> 00:31:52.410

more coming down the road as we're especially changing executive administrations.

00:31:52.730 --> 00:31:56.870

And as you said, Jason, so all of this could change tomorrow.

00:31:57.130 --> 00:32:02.490

So it is a point in time, but it's good from a pharmacist's perspective to hear

00:32:02.490 --> 00:32:08.190

an easy explanation of some of these things that are not in our daily vocabulary.

Subscribe Now for Exclusive Access

Don’t miss out on critical updates and game-changing strategies. Subscribe to 340Banter today and ensure your FQHC is always a step ahead in 340B compliance.

"A lot of people don't know that pharma filed suit against HRSA in 1996 when the first contract pharmacy guidance came out and they actually pulled it back due to pushback from Ryan White clinics."

-Jason Reddish

About FQHC 340B Compliance

340Banter is brought to you by FQHC 340B Compliance, a trusted partner in optimizing 340B Programs for Federally Qualified Health Centers nationwide. Their mission is to provide tailored resources to help health centers secure and optimize their 340B Programs, improving compliance and oversight. For more information, contact us!

Subscribe now

Find Our Podcast On Your Favorite Platform

Have Questions? Let's Talk.

Contact us

Have a question for our team, topic suggestions, or want to be a featured guest? Reach out to us!

Empowering Healthcare Professionals. Enhancing 340B Performance.